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CHAPTER I 
 
INTRODUCTION 
 
THE CELL DIVISION CYCLE 
The process of cell divison involves the exact duplication and equal distribution 
of the cellular components, including the genetic material, between two daughter cells. A 
complex network of regulatory components controls the progression through each stage 
of the cell cycle. Cell-cycle events and machinery are similar among all eukaryotic cells, 
making it possible to study cell-cycle control in diverse experimental systems. Research 
from a number of model systems, including the fission yeast Schizosaccharomyces 
pombe, the budding yeast Saccharomyces cerevisiae, the fruit fly Drosophila 
melanogaster, and the frog Xenopus laevis, has provided tremendous insight into cell-
cycle regulation (Thuriaux et al., 1978; Forsburg and Nurse, 1991; Lee and Orr-Weaver, 
2003; Philpott and Yew, 2008). In single-cell organisms, cell division results in new 
daughter organisms. In multi-cellular organisms, cell division is essential for the 
development of all tissues and organs within the organism. Cell division is a fundamental 
facet of life, whereas the erroneous segregation of genetic information may result in 
developmental disorders or disease states, such as cancer. 
The genetic material of eukaryotic cells is in the form of DNA, which is packed 
into discrete DNA-protein structures called chromosomes. Chromosomes and other 
cellular components must be duplicated once per cell cycle. The canonical cell division 
cycle involves alternating rounds of DNA replication (DNA synthesis, S phase), in which 
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the chromosomes are duplicated, and mitosis (M phase), in which the sister chromatids 
are segregated to the two daughter cells (Fig. 1.1). The canonical cell cycle also consists 
of intervening gap phases: G1, occurring after mitosis, and G2, occurring after S phase. 
These two gap phases allow time for cellular growth and serve as important regulatory 
points to monitor the success of previous cell cycle events. These monitoring stages are 
called checkpoints, which act as molecular brakes to prevent progression to the next cell 
cycle stage when spindle or genomic errors are detected. 
When mitosis is complete, the new nuclei and organelles must be distributed into 
separate daughter cells. The resulting daughters should each contain one nucleus, one 
centrosome, and an equal distribution of cellular organelles. The timing of the separation 
process, termed cytokinesis, is coordinated with the completion of mitosis. In most 
eukaryotic cells, a contractile ring, made up of actin bundles and myosin motors, carries 
out the mechanics of cytokinesis.  
 
CELL-CYCLE REGULATION 
Progression through the cell cycle is largely controlled by protein heterodimers of 
Cyclin dependent kinases (Cdks) and cyclins. The activities of the highly conserved Cdks 
rise and fall throughout the cell cycle. Association with cyclin proteins via the PSTAIR 
domain is required for Cdk activity (Morgan, 1996). Cyclins are synthesized and 
degraded to regulate progression through the cell cycle (Murray and Kirschner, 1989; 
Glotzer et al., 1991). This oscillatory degradation of cyclins also promotes irreversibility 
of the cell cycle. Different types of Cdks and cyclins are needed at different cell cycle 
stages; the resulting Cdk-cyclin combinations control the complexity and periodicity of 
 3 
 
Figure 1.1 Cell division cycles throughout development. Early embryonic cell cycles 
of Drosophila, Xenopus and zebrafish consist of rapid, repeating rounds of DNA 
synthesis (S phase) and mitosis (M phase) with no intervening gap phases. Eventually, a 
G2 phase is introduced in these organisms at an important developmental switch called 
the mid-blastula transition (MBT). There also specialized cell cycles during 
gametogenesis and organogenesis during which cells undergo endoreplication cycles 
(endocycles); these cycles consist of repeating rounds of S phase and growth (G) without 
intervening mitoses and result in polyploidy. The canonical cell division cycle involves 
alternating rounds of S phase and M phase with two intervening gap phases: G1, 
occurring after M phase of the previous cycle, and G2, occurring after S phase. 
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the cell cycle. In budding and fission yeasts, a single Cdk is present in association with 
cell cycle stage-specific cyclins. In mammals, Cdk4/cyclin D and Cdk6/cyclin D are 
active during G1 to promote cell growth and transition to S phase, respectively. 
Cdk2/cyclin E promotes entry into S phase, Cdk2/cyclin A is required for completion of 
S phase, and Cdk1/cyclin A is required for entry into mitosis. Cdk1/cyclin B is required 
during early mitosis prior to the metaphase to anaphase transition. For the cell to progress 
through mitosis, cyclin A must be degraded during prometaphase to transition to 
metaphase and cyclin B must be degraded at metaphase to transition to anaphase 
(reviewed by Morgan, 1997). This orchestrated modulation of Cdks/cyclins is the engine 
that drives cell cycle progression. 
In addition to requisite cyclin partners, Cdks are subject to additional layers of 
regulation. Cdks are positively regulated by phosphorylation by the kinase Cdk-activating 
kinase (CAK), which is a complex of Cdk7/cyclin H. Phosphorylation of Cdk by CAK 
results in a conformational change to make the Cdk catalytic domain accessible (Lees, 
1995). Cdks are also negatively regulated by phosphorylation; Wee1 and Myt1 kinases 
are responsible for phosphorylating Cdk1 in order to prevent mitotic entry (Gould and 
Nurse, 1989). These inhibitory phosphorylation events are counteracted by the activity of 
phosphatases such as Cdc25, which is essential to activate Cdk1/cyclin B for the onset of 
mitosis (Lew and Kornbluth, 1996). There are also Cdk kinase inhibitors (CKIs) that bind 
Cdks to keep them inactive (Elledge and Harper, 1994). These mechanisms generate an 
irreversible feedback loop that controls the activity of Cdks during cell cycle progression. 
Cyclin protein levels are also highly regulated by the ubiquitin-proteasome system (UPS), 
which is discussed later in this chapter (Glotzer et al., 1991). 
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CELL CYCLES THROUGHOUT DEVELOPMENT 
There are several “variant” cell cycles that occur during the development of a 
multicellular organism. These modified cell cycles are specialized, but essential for the 
development and physiology of many organisms. In some organisms, the early embryo 
employs a simplified cell cycle consisting of rapid, repeating rounds of DNA replication 
and mitosis with no intervening gap phases (Fig. 1.1). Such cell cycles are present in the 
early embryos of Drosophila melanogaster, Xenopus laevis, and the zebrafish Danio 
rerio (O’Farrell, Stumpff, and Su, 2004; Budirahardja and Gönczy, 2009). The rapid 
early embryonic cell cycles of these organisms may have evolved for speed due to the 
exposed environment in which the animals develop. In these early embryonic cycles, cell-
cycle regulators in the form of mRNA or protein are provided maternally and slowly 
depleted. Eventually, a G2 phase is introduced in these organisms at an important 
developmental switch called the mid-blastula transition (MBT). This also marks the 
general depletion of the maternal contribution and the onset of transcription of the 
zygotic genome. As with most cell cycle events, the introduction of a G2 phase and the 
developmental switch at the MBT are controlled by the activity of Cdks/cyclins (Lee and 
Orr-Weaver, 2003; Newport and Kirschner, 1984). The regulation of the early embryonic 
cell cycles of Drosophila is discussed later in this chapter. 
As development continues, the cell cycles of most organisms become more 
complex. Typically, the cell cycle after early embryogenesis is canonical in nature, as 
described earlier in this chapter (Fig. 1.1). There are also examples of variant cell cycles 
in gametogenesis and organogenesis. For instance, there are several examples of 
organisms with polyploid cells, which contain more than two copies of the genome. In 
 6 
Drosophila, the oocyte-supporting nurse cells are polyploid as a consequence of 
endoreplication cycles (endocycles), which consist of repeated rounds of S phase without 
intervening mitoses (Lee et al., 2009). Another type of endocycling cell is the placental 
mouse trophoblast giant cell (TGC), which is crucial for embryo implantation in the 
uterus (Hoffman and Wooding, 1993). Perturbation of endocycles may result in sterility 
or organ malfunction.  
 
EARLY DROSOPHILA EMBRYOGENESIS 
The cell cycles of the early embryo of Drosophila are streamlined in nature, thus 
making it an ideal model system for studying cell-cycle regulation in a multicellular 
organism. Other major advantages of Drosophila as an experimental system include the 
feasibility of using genetics, cell biology, and biochemistry in examining mutant 
phenotypes. Early Drosophila embryogenesis consists of thirteen rapid S-M (DNA 
Synthesis-Mitosis) cycles driven by stockpiles of maternally deposited mRNA and 
protein in a shared cytoplasm (syncytium). These early cell cycles are ~10 minutes in 
length and consist of oscillating DNA replication and mitosis with no intervening gap 
phases or cytokinesis (Lee and Orr-Weaver, 2003). Zygotic transcription of most genes 
does not begin until the fourteenth cycle when cellularization occurs and a G2 phase is 
introduced at the MBT.  
The timing of the early Drosophila cell cycles is mostly regulated by the localized 
accumulation and degradation of cyclins A and B, but the overall pool of cyclin levels 
remain constant during the early preblastoderm divisions (Edgar et al., 1994). Global 
cytoplasmic movement and a local oscillation of cyclin concentration are the key factors 
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in regulating mitosis during early embryonic cell cycles (Ji et al., 2004; Stiffler et al., 
1999; Crest et al., 2007). The levels of Drosophila Cdc25, String, gradually rise during 
the first eight syncytial cycles, and then gradually decline; String phosphorylation also 
fluctuates during these early mitoses (Edgar et al., 1994). Interestingly, however, Cdk1 
phosphorylation is not detectable during these cycles, suggesting that inhibitory 
phosphorylation of Cdk1 does not occur during the syncytial cell cycles of Drosophila 
embryogenesis. As the embryo approaches the MBT and a G2 phase is introduced, the 
levels of maternal String, Cdk1, and cyclins gradually decline, which allows for the 
switch to zygotic transcription and more canonical cell-cycle regulation. 
 
THE DNA DAMAGE RESPONSE 
In order to monitor the integrity of the genome and to prevent the transmission of 
genetic errors to daughter cells during cell division, the cell employs regulatory proteins 
that provide a safeguard mechanism to block cell-cycle progression in the presence of 
genomic damage. DNA damage can be present at any stage of the cell cycle and exists in 
many forms, ranging from small single nucleotide alterations to DNA double-strand 
breaks. DNA damage may also result from many different sources, including 
spontaneous mutations, chemicals, or radiation. Approximately 30,000 DNA lesions 
spontaneously occur in a single mammalian cell per day, highlighting the extensive 
workload presented to the cell to identify and correct lesions (Lindahl and Barnes, 2000). 
Utilizing a complex network of machinery, the cell will attempt to repair the DNA 
damage once it has been recognized. The goal of the DNA damage response (DDR) is to 
prevent transmission of mutated genetic material to progeny (reviewed by (Zhou and 
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Elledge, 2000). If the DDR is perturbed, this may result in unrepaired DNA damage and 
uncontrolled proliferation. When mutated DNA is passed to a cell’s offspring, the 
viability of the daughter cells is at stake. In a multicellular organism, this will initially 
only affect a small population of cells; however, if uncontrolled proliferation is allowed 
to continue, pathologies such as cancer can result. 
 
MECHANISMS OF DNA DAMAGE DETECTION AND REPAIR 
DNA damage must first be detected by proteins monitoring the integrity of the 
genome at distinct transitions of the cell cycle. In all eukaryotic cells, the DDR is 
controlled by the Phosphoinositide 3 (PI3)-related kinases: Ataxia Telangiectasia 
Mutated (ATM) and ATM-related (ATR). These “sensors” associate with damaged DNA, 
which results in their phosphorylation and activation of the “effector” kinases: 
Checkpoint kinases 1 and 2 (Chk1 and Chk2). This signaling cascade responds to DNA 
damage and can activate additional signaling events to repair the damage.  
The three possible outcomes of the DDR are DNA repair, cell-cycle arrest or cell 
death. Some forms of DNA damage can be repaired quickly and do not cause the DDR to 
trigger a cell-cycle arrest; however, some lesions are more harmful, and a cell-cycle 
block is initiated. When DNA damage or incomplete DNA replication is detected, the cell 
activates ATM/ATR to phosphorylate Chk1 and other substrates. Chk1 phosphorylates its 
downstream targets, such as Cdc25, to initiate a cell-cycle arrest. Cdc25 phosphatases 
remove the inhibitory phosphates from Cdks, thereby promoting cell-cycle progression. 
Phosphorylation of Cdc25 in response to checkpoint activation results in its 
destabilization and cell-cycle delay (Furnari et al., 1997). In other cases, the damage is so 
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severe or the cell cycle machinery is so perturbed that the cell initiates programmed cell 
death (apoptosis) (Harper and Elledge, 2007). 
In the presence of single-stranded DNA, RPA (replication protein A) recruits 
ATR and its adapter protein, ATRIP (ATR-interacting protein), which results in the 
recruitment of the 9-1-1 (Rad9/Hus1/Rad1) complex (Cortez et al., 2001; Ball et al., 
2005; Yang and Zou, 2006). Once ATR is activated, it phosphorylates the effector protein 
Chk1, which can in turn phosphorylate its downstream substrates. In the presence of 
double-stranded DNA breaks, ATM (and sometimes ATR) is recruited by components of 
the MRN (Mre11/Rad50/Nbs1) complex, which directs repair of the double-strand break 
(Lee et al., 2010). In mammalian cells, ATM phosphorylates H2A.X, a variant form of 
Histone H2A, at sites of double-strand breaks (Burma et al., 2001). There are also several 
“adaptor” proteins, such as BRCA1 and 53BP1, that are both regulated by and help to 
regulate the DDR.  
In animal cells, but not in budding or fission yeasts, the DDR may result in 
permanent cell-cycle arrest or cell death. This additional level of protection for the 
organism is largely controlled by the tumor suppressor p53, the single most frequently 
mutated protein in cancer cells (Soussi, 2003). p53 is a transcription factor that is 
activated by ATM and ATR and is required to initiate transcription of downstream target 
genes involved in preventing cell-cycle progression and triggering apoptosis (Hirao et al., 
2000). A major target of p53 is the Cdk inhibitor p21, which inhibits Cdk/cyclin and 
prevents cell-cycle progression at G1/S (Shivji et al., 1994). If the DDR is unable to 
repair the damage in a timely manner, cells may initiate p53-mediated apoptosis.  
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THE DNA CHECKPOINT IN THE EARLY DROSOPHILA EMBRYO 
The syncytial Drosophila embryo lacks a canonical G2 phase (Fig. 1.1). During 
early Drosophila embryogenesis, mei-41, the ATR homolog, and grapes (grp), the Chk1 
homolog, are required to slow the late syncytial cell cycles (11-13) in order to introduce a 
G2 phase at cellularization (Sibon et al., 1999; Fogarty et al., 1994; Sibon, Stevenson, 
and Theurkauf, 1997). These checkpoint kinases are not activated in the early embryo in 
response to DNA damage or incomplete replication until late syncytial divisions. mei-
41/grp promote Cdk1 inhibitory phosphorylation to allow the switch to zygotic control at 
the MBT after cycle 13. According to a well-accepted model, critical replication factors 
are depleted near the end of syncytial embryogenesis, and mitotic entry is likely slowed 
in these cell cycles to allow time to complete replication (Sibon, Stevenson, and 
Theurkauf, 1997; Crest et al., 2007; McCleland, Shermoen, and O’Farrell, 2009; Lu et 
al., 2009). Embryos from mei-41 or grp mutant females fail to lengthen interphase in 
these cycles and enter mitosis with incompletely replicated DNA. 
 
CHECKPOINT KINASE 2-MEDIATED CENTROSOMAL INACTIVATION IN 
THE EARLY DROSOPHILA EMBRYO 
When DNA damage or incomplete DNA replication occurs in the early 
Drosophila embryo, as in the mei-41 or grp-derived embryos, Checkpoint kinase 2 
(Chk2) is activated in the vicinity of affected nuclei. This causes a cell-cycle arrest with 
centrosomal, spindle, and chromosomal defects (Takada et al., 2007). This Chk2-
dependent phenomenon, referred to as centrosomal inactivation, occurs as a result of 
dissociation of γ-tubulin ring complex (γTuRC) proteins from core centrosomal subunits 
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(Sibon et al., 2000; Takada et al., 2003). Defective Chk2-activated nuclei drop into the 
interior of the embryo in later syncytial cycles and are not cellularized at the MBT, so as 
to be excluded from the embryo proper. This culling of Chk2-activated nuclei with 
damaged or incompletely replicated DNA protects the genomic integrity of the 
developing Drosophila embryo. In mammalian cells, Chk2 is localized to the centrosome 
and inhibition of centrosome separation has been observed in response to DNA damage 
(Fletcher et al., 2004; Fletcher and Muschel, 2006). Whether or not a similar role for 
Chk2 in centrosomal inactivation occurs in mammalian cells remains controversial 
(Song, 2005).  
 
CELL CYCLE MISREGULATION AND TUMORIGENESIS 
The importance of the DDR is evident in the human diseases caused when it is 
missing or dysfunctional. Spontaneous mutations arise with each cell division, and if 
those mutations are not corrected or if the mutated cells are not prevented from dividing, 
DNA damage will accumulate. This may eventually result in misregulated cell growth 
and division and ultimately increase the likelihood of cancer. Cancer is uncontrolled cell 
growth, which can result from the mutation or dysfunction of key cell-cycle regulators. 
When cancer cells invade neighboring cells and tissue, this is termed metastasis. A 
predisposition to cancer may be inherited genetically, when a mutation or multiple 
mutations are transmitted from parent to progeny. Mutations resulting in cancer may also 
occur spontaneously or as a consequence of the environment. Chemicals and radiation 
from the environment can be toxic to the genome and cause a range of damage to the 
DNA, from single nucleotide alterations to breaks in the double helix. Cancer has 
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recently been the leading cause of death in economically developed countries and the 
second leading cause of death in developing countries (Jemal et al., 2011). A more 
complete understanding of the cell-cycle machinery and how cancers progress will 
potentially lead to more effective therapeutics in order to fight these diseases. 
Cell-cycle dysfunction during the development of multicellular organisms is also 
a potential cause of pathogenesis. Cell-cycle components must be properly functioning 
and regulated during critical developmental stages; if their regulation is perturbed, 
sterility or developmental disorders may result. For example, the exact timing of the 
degradation of CDC25-1 during embryogenesis of the nematode Caenorhabditis elegans 
is needed to establish the development of the gut and the germline (Bao et al., 2008). 
Without the establishment of these crucial cell lineages, the survivability of the 
developing organism is at stake.  
 
PROTEIN UBIQUITYLATION 
A posttranslational modification of proteins that involves the covalent attachment 
of ubiquitin was discovered by Aaron Ciechanover, Avram Hershko and Irwin Rose in 
the early 1980s (Hershko et al., 1980, 1983; Hershko and Ciechanover, 1998). 
Ubiquitylation is a highly dynamic, multi-step process that involves four key 
components: a ubiquitin activating enzyme (E1), ubiquitin conjugating enzymes (E2s or 
Ubcs), ubiquitin ligases (E3s), and ubiquitin (Ub) (reviewed by Fang and Weissman, 
2004; Weissman, 2001; Wilkinson, 2000) (Fig. 1.2). Ubiquitin is a small (76 amino 
acids) protein that is highly conserved and universally distributed among all eukaryotic 
cells. Ubiquitylation can involve the linkage of one or more Ub molecules to another 
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protein. Protein ubiquitylation may alter its fate in a number of ways, including the 
following: targeting it for destruction by the 26S proteasome, changing its subcellular 
location, or changing its protein-protein interactions (Glickman and Ciechanover, 2002). 
Protein ubiquitylation affects a variety of cellular processes, such as protein processing, 
cell cycle control, chromatin remodeling, DNA repair and membrane trafficking (Liu and 
Chen, 2011; Broemer and Pascal Meier, 2009; Le Bras et al., 2011; Acconcia et al., 2009; 
Hershko, 1997; Al-Hakim et al., 2010; O’Connell and Harper, 2007). 
 
MECHANISM OF PROTEIN UBIQUITYLATION 
The ubiquitylation process begins when an E1 enzyme activates Ub at its carboxy 
terminus to form a thiolester bond between E1 and Ub in an ATP-dependent mechanism 
(Fang and Weissman, 2004). Ub is then transferred by an E2 enzyme, in association with 
an E3 ligase, to its substrate protein. Ub attaches to substrates via isopeptide bonds at key 
lysine residues. In the final step of the “canonical” ubiquitin-proteasome pathway, the 
26S proteasome recognizes ubiquitylated proteins, which are degraded into smaller 
peptides in an ATP-dependent manner. To  begin a new cycle, Ub molecules are recycled 
by deubiquitylating enzymes (DUBs) (Komander et al., 2009). In S. cerevisiae, there is 
one E1, 11 E2s, and >50 E3s (Chan and Hill, 2001). In Drosophila, there is one E1, ~40 
E2s, and ~130 E3s as predicted by database searches. Drosophila has 61% fewer 
components of the ubiquitylation machinery than humans, making it an attractive model 
organism for studying protein ubiquitylation in a multicellular context (Ditzel and Meier, 
2005; Bergmann, 2010). 
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Figure 1.2 Mechanisms of protein ubiquitylation. Modification of proteins by 
ubiquitylation is a multi-step process that involves four key components: an ubiquitin 
activating enzyme (E1), an ubiquitin conjugating enzymes (E2), an ubiquitin ligase (E3), 
and ubiquitin (Ub). E1 enzyme activates Ub in an ATP-dependent mechanism to form a 
thiolester bond between E1 and Ub. Ub is then transferred to an E2 enzyme. The E3 
associates with an E2 via its RING domain, as well as with its substrate protein. The E2 
transfers Ub to the substrate via isopeptide bonds at key lysine residues. The attachment 
of Ub to its substrate may involve a single Ub molecule (monoubiquitylation) or multiple 
Ub molecules to each other to form an Ub chain (polyubiquitylation). In an Ub chain, Ub 
molecules may be linked together via any of Ub’s seven lysine (K) residues, resulting in 
K48, K63, K11, K29, K33, K6, or K27 linkages. 
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Not all ubiquitylated proteins are targeted to the 26S proteasome for degradation. 
Determining factors that regulate the fate of a substrate include the site(s) of modification 
and the structure of the ubiquitin chain (if polyubiquitylated). The attachment of Ub to its 
substrate may involve a single Ub molecule (monoubiquitylation), multiple Ub molecules 
to several sites on the same substrate protein (multiubiquitylation), or multiple Ub 
molecules to each other to form a Ub chain (polyubiquitylation). Monoubiquitylation has 
been implicated in a number of cellular processes, including DNA repair and membrane 
trafficking (Al-Hakim et al., 2010; Haglund et al., 2003; Lee and Myung, 2008). The 
occurrence of poly-Ub chains in vivo at each of Ub’s seven lysine residues has been 
reported (Xu et al., 2009). When Ub forms a chain, individual Ub molecules may be 
linked together via lysine 48 (K48), lysine 63 (K63), lysine 11 (K11), lysine 29 (K29), 
lysine 33 (K33), lysine 6 (K6), or lysine 27 (K27) of Ub (Fig. 1.2) (Johnson et al., 1995; 
Hatakeyama et al., 2001; Kirkpatrick et al., 2006; Nishikawa et al., 2004). Although the 
K48-linkage typically serves as a degradation signal and is the most widely studied Ub 
linkage, other Ub sites have been shown to be involved in important cellular processes. 
For example, Ub chains linked via K63 are important in DNA repair, NF-κB activation 
and endocytosis (Panier and Durocher, 2009; Iwai and Tokunaga, 2009; Lauwers et al., 
2010). K63-linkages often act as non-proteolytic signals, suggesting that Ub chains serve 
as distinct signals within the cell, resulting in specific and varied downstream cellular 
events. 
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E3 UBIQUITIN LIGASES 
E3 ubiquitin ligases serve as the specificity factors during ubiquitylation, as they 
bind both the E2 conjugating enzyme (E2) and the substrate to be ubiquitylated. There 
are two main classes of E3s: HECT (Homologous to the E6-AP Carboxyl Terminus) 
domain-containing E3s and RING (Really Interesting New Gene) domain-containing E3s 
(Bernassola et al., 2008; Deshaies and Joazeiro, 2009). The RING-type E3 ubiquitin 
ligase contains a specialized zinc finger motif consisting of 40 to 60 residues that binds 
two atoms of zinc. This domain is likely involved in mediating protein-protein 
interactions, most commonly to its partner E2(s) (Joazeiro and Weissman, 2000). The 
RING domain structure is referred to as a ‘cross-brace’ motif because of the spacing of 
zinc ions within the motif. There are two different classes of RING domains that differ in 
their cysteine/histidine pattern: the C3HC4-type and the C3H2C3-type, which is also 
referred to as the RING-H2-type (Ardley and Robinson, 2005). 
 
PROTEIN UBIQUITYLATION AND DEGRADATION DURING THE CELL 
CYCLE 
During the cell cycle, ubiquitylation temporally controls the degradation of many 
proteins, including the mitotic cyclins. Two multi-subunit E3s involved in promoting the 
ubiquitin-mediated proteolysis of cell cycle components are the Anaphase-Promoting 
Complex/Cyclosome (APC/C) and the SCF (Skp1/Cullin/F-box) complex. The SCF 
complex consists of three core subunits, the RING protein Rbx1, the Cullin Cul1, and 
Skp1. The substrate binds to a substrate-specific F-box protein that is also bound to the 
Skp1 subunit of the SCF. The SCF complex is responsible for ubiquitylating and 
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degrading G1/S cyclins, Cdk1 inhibitors, and other cell cycle components (Skaar and 
Pagano, 2009). 
The APC/C consists of twelve subunits, including a RING-containing subunit 
APC11, and is active at the metaphase to anaphase transition through G1 (Simpson-Lavy 
et al., 2010; Manchado et al., 2010). The APC/C must first be activated by one of its 
effector proteins, Cdc20 or Cdh1. Cdc20 (Fizzy in Drosophila) activates the APC/C at 
the metaphase to anaphase transition and is responsible for the ubiquitylation and 
destruction of Securin, which allows for the release of Separase. Once free, Separase 
destroys sister-chromatid cohesion and allow for the progression to anaphase. Mitotic 
cyclins are also degraded by the APC/C at metaphase to inactivate Cdk1. Cdh1 (Fizzy-
related in Drosophila) activates the APC/C in late mitosis to ensure that S phase and 
mitotic cyclin levels are kept low and Cdk1 activity is inhibited. At the end of G1, the 
APC itself is targeted for degradation in order for cyclin levels to rise and initiate S 
phase. 
 
DNA REPLICATION AND THE IMPORTANCE OF PCNA 
Duplication of the genome occurs during S phase, and the accurate transmission 
of the genetic material to the daughter cells is necessary to maintain genomic integrity. 
DNA replication is the process by which the genome is duplicated, and normally this 
occurs rapidly and with high accuracy in eukaryotic cells (2900 bases per minute) 
(Moldovan et al., 2007). Beginning at regions of the DNA called origins of replication, 
DNA replication is initiated when a pre-replicative complex (pre-RC) is formed during 
G1, thereby licensing the cell to begin S phase. The formation of the pre-RC is catalyzed 
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by the binding of the proteins Cdc6 and Cdt1 to the six-subunit ATPase called the origin 
recognition complex (ORC) at sites of replication (replication foci) (Prasanth et al., 
2004). Once an origin is activated, the pre-RC disassembles and cannot reassemble until 
the next G1, allowing only one round of duplication of the genome per cell cycle. DNA 
replication proceeds when Polα, the priming DNA polymerase, binds the DNA synthesis 
machinery at the replication fork and begins to synthesize new DNA strands. The 
replicative polymerases, Polδ and Polε, continue DNA replication until the entire 
chromosome is duplicated. 
One of the key players in both DNA synthesis and DNA repair is the 
homotrimeric DNA clamp Proliferating cell nuclear antigen (PCNA). This sliding clamp 
protein is structurally and functionally conserved in all eukaryotes. PCNA forms a ring-
like structure that encircles the DNA during replication and serves as a linker between 
DNA and the replicative DNA polymerase (Polδ or Polε). PCNA is considered a 
processivity factor during DNA replication; studies in budding yeast have shown that its 
presence increases the progression and accuracy of DNA polymerases 100-fold (Arroyo 
et al., 1996). PCNA is also involved in many DNA repair processes, including the 
prevention of sister-chromatid recombination, mismatch repair (MMR), base excision 
repair (BER), and nucleotide excision repair (NER) (reviewed by Moldovan et al., 2007).  
 
PCNA REGULATION DURING DNA REPLICATION AND REPAIR 
PCNA activity is highly regulated by posttranslational modifications. PCNA 
undergoes monoubiquitylation, polyubiquitylation, and sumoylation in response to 
different cellular signals (reviewed by Shaheen et al., 2010; Lee and Myung, 2008; 
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Moldovan et al., 2007). While some of the enzymes responsible for modifications on 
PCNA have been uncovered, the signaling events that lead to these events are not well 
understood. Furthermore, while many of the players in PCNA regulation have been 
reported in budding and fission yeasts, much less is known about PCNA regulation in 
higher organisms.  
In S. cerevisiae, PCNA is monoubiquitylated by the E3 ubiquitin ligase Rad18 in 
conjunction with the E2 conjugating enzyme Rad6 in response to a stalled replication 
fork (Bailly et al., 1997). Monoubiquitylation of PCNA at lysine 164 (K164) in turn 
recruits a specialized DNA polymerase needed to bypass the damaged DNA in a process 
called translesion synthesis (TLS), which is discussed later in this chapter (Haracska et 
al., 2006). PCNA is also sumoylated at K164 in order to prevent recombination and 
sister-chromatid cohesion during S phase (Watts, 2006). When the DNA damage is so 
severe that TLS cannot bypass the lesion at the stalled replication fork, a K63-linked 
polyubiquitin chain is elongated from the monoubiquitin on PCNA by another E2/E3 
complex, MMS2-Ubc13/Rad5 (Broomfield et al., 1998; Torres-Ramos et al., 2002; 
Haracska et al., 2006). This polyubiquitylation of PCNA inhibits TLS and initiates an 
error-free pathway of DNA repair; replication is formally stalled until the lesion is 
successfully corrected. 
In mammalian cells, PCNA regulation is more complex, and the components 
involved in these events are less well understood. Similar to budding and fission yeast, 
PCNA is monoubiquitylated by the E2/E3 pair Rad6B/Rad18 in order to initiate TLS 
(Hoege et al., 2002). Although Rad18 is essential for TLS activation in mammalian cells, 
Rad18-independent monoubiquitylation of PCNA has been reported (Simpson et al., 
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2006). PCNA has also been shown to be polyubiquitylated in mammalian cells, although 
identification of the E2(s)/E3(s) responsible for this modification is still uncertain. The 
mammalian E3 ligase Rad5 homologs are HLTF (helicase-like transcription factor) and 
SHPRH (SNF2 histone linker PHD RING helicase), and polyubiquitylation of PCNA by 
these E3 ligases has been shown in cells overexpressing these proteins (Unk et al., 2006; 
Motegi et al., 2008; Lin et al., 2011; Krijger et al., 2011). These studies reported HLTF 
and SHPRH independently catalyze a K63-linked polyubiquitin chain on PCNA, and this 
modification prevents TLS without promoting the degradation of PCNA. Double 
knockout mice lacking these E3s are viable, however, and PCNA polyubiquitylation 
occurs normally in MEFs (mouse embryonic fibroblasts) derived from the doubly mutant 
embryos (Krijger et al., 2011). These data suggest that other E3 ligases are likely 
important for PCNA regulation in higher organisms, either in concert with, or 
independent of, the Rad5 homologs HLTF and SHPRH. 
It is worth noting that PCNA was originally considered a “cyclin,” as its protein 
levels oscillate during the cell cycle in higher eukaryotes (Moldovan et al., 2007). As 
suggested by its name, PCNA levels are high in dividing cells, but levels peak in S phase. 
PCNA levels are thought to be regulated by the ubiquitin-proteasome system throughout 
the cell cycle, although the enzymes and resulting modifications responsible for its 
degradation have not yet been reported.  
 
TRANSLESION DNA SYNTHESIS 
As discussed previously, the threat of DNA damage can be addressed using a 
number of cellular responses. The eukaryotic cell possesses many mechanisms to repair 
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DNA damage, such as homologous end-joining, non-homologous end-joining (NHEJ), 
homologous recombination, single-strand annealing, NER, BER, and MMR. Cells also 
possess mechanisms to temporarily tolerate DNA damage until the DNA repair 
machinery can effectively correct the problems. These “tolerant” processes, which 
include two parallel pathways, are triggered during S phase when the replication 
machinery senses damage (Waters et al., 2009). Translesion synthesis (TLS) is one 
measure taken to bypass damaged DNA during S phase (Fig. 1.3). This process is 
mediated by PCNA and its recruitment of non-canonical DNA polymerases to sites of 
damage (reviewed by Shaheen et al., 2010; Lehmann, 2006). These specialized 
polymerases include Polζ (also referred to as DNA polymerase zeta or Rev3), a member 
of the B family of DNA polymerases, and members of the Y family of DNA 
polymerases; the latter, consisting of Rev1, Polι, Polη, and Polκ, are discussed in the 
next section (Waters et al., 2009). Although the genes encoding the TLS polymerases 
have been known for about 40 years, it is only in the past decade that the process of TLS 
and the associated DNA polymerases has been studied in detail (Lemontt, 1971; Waters 
et al., 2009). 
TLS promotes the completion of DNA replication, instead of repairing damaged 
DNA. The process is initiated by the monoubiquitylation of PCNA on K164 by 
Rad6/Rad18, which subsequently triggers the recruitment of translesion DNA 
polymerases to the replication fork (Friedberg et al., 2002). The TLS polymerases use the 
damaged DNA as a template to incorporate a nucleotide opposite to the lesion. 
Sometimes this incorporation occurs with high accuracy; at other times, however, the 
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bypass event is mutagenic and must be repaired later. The mechanism of TLS by the Y 
polymerases is discussed in more detail below. 
 
THE Y FAMILY OF DNA POLYMERASES 
DNA polymerases are enzymes that incorporate deoxynucleotides into DNA 
during replication or repair. DNA polymerases play an essential role in duplicating the 
genome and preserving genomic integrity. The Y family of DNA polymerases is 
composed of non-canonical DNA polymerases that facilitate TLS. These specialized 
polymerases have been shown to interact with monoubiquitylated PCNA at the 
replication fork in response to the detection of DNA lesions (Andersen et al., 2008). 
From studies in bacteria, yeasts and mammalian cells, ultraviolet (UV) light has been 
shown to be a major trigger to recruit Y-family polymerases to monoubiquitylated PCNA 
at sites of stalled replication forks (Waters et al., 2009). In unchallenged cells, Y-family 
polymerases are localized diffusely throughout the nucleus during interphase. In the 
presence of UV, however, the polymerases appear as nuclear foci during S phase 
(Andersen et al., 2011). 
The Y family of DNA polymerases is conserved from bacteria to humans (Waters 
et al., 2009; Jarosz et al., 2007; Lehmann, 2006). In mammals, there are four Y-family 
DNA polymerases: Polκ (POLK), Polι (POLI), Polη (POLH) and REV1. The members 
of the Y family of polymerases have several conserved protein domains that allow them 
to interact with their associated binding partners and to effectively mediate TLS. All four 
mammalian polymerases have a catalytic DNA polymerase domain at their amino termini 
(Parker et al., 2007; Prakash et al., 2005; Lehmann, 2006). They also all have ubiquitin 
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binding domains, either in the form of UBMs (ubiquitin-binding motifs) or UBZs 
(ubiquitin-binding ZnF domains). The Y polymerases can interact with each other. 
POLH, POLI and POLK can all interact with REV1 via defined REV1-interacting 
domains; REV1, in turn, has a defined region at its carboxy terminus that is responsible 
for its interaction with the other Y polymerases (Ross et al., 2005; D’Souza and Walker, 
2006). POLH, POLI and POLK have PCNA interacting domains called PIP (PCNA-
interacting peptide) boxes. Interestingly, POLH, POLI and POLK interact directly with 
PCNA via a PIP box and indirectly via an ubiquitin-binding domain. These domains are 
necessary for the recruitment and interaction of Y-family DNA polymerases with 
monoubiquitylated PCNA and are also essential for their function in TLS (Haracska et 
al., 2006; Acharya et al., 2008; Bienko et al., 2005; Andersen et al., 2008). 
Mutation of one of the human Y-family DNA polymerases, POLH, results in 
Xeroderma Pigmentosum Variant (XP-V), a disease characterized by UV sensitivity with 
increased incidence of skin cancer (Masutani et al., 1999; Kannouche and Stary, 2003; 
Kannouche et al., 2001). A mouse model of XP-V developed by generating polh-/- null 
mutants exhibit high mutation frequencies and UV-induced epithelial tumors (Busuttil et 
al., 2008; Ohkumo, Kondo, et al., 2006). The high frequency of mutations in individuals 
with XP-V supports the model that POLH is needed to bypass lesions during TLS and 
also suggests that other DNA polymerases that compensate for a POLH-deficiency are 
highly inaccurate at bypassing UV-induced lesions. These observations challenge the 
preconceived idea that TLS is an error-prone pathway in response to UV. 
The Drosophila genome encodes three members of the Y family of DNA 
polymerases: DNApol-eta, DNApol-iota and Rev1. Little has been reported on 
 24 
Drosophila Y polymerases, and there are currently no reported mutant alleles for these 
genes in flies. As in other organisms, recombinant Drosophila DNApol-eta and DNApol-
iota proteins function as translesion polymerases in vitro (Ishikawa et al., 2001). Domain 
mapping of the protein-protein interactions between fly Y polymerases has also been 
reported. These data show that DNApol-eta and DNApol-iota both interact with Rev1 via 
yeast two-hybrid assays (Kosarek et al., 2008). Interactions of the Y-family polymerases 
with each other are consistent with reports for the Y polymerases conserved in budding 
and fission yeast, C. elegans and mammals. 
 
MODELS FOR LESION BYPASS BY TLS POLYMERASES 
The polymerase-switching model proposes a mechanism of lesion bypass at the 
replication fork (Kannouche et al., 2004; Friedberg et al., 2005; Lehmann et al., 2007; 
Kannouche and Lehmann, 2004; Andersen et al., 2011). TLS polymerases are first 
recruited and activated by their interaction with monoubiquitylated PCNA at the 
replication fork in the presence of damaged DNA (Fig. 1.3). The first switch occurs when 
the TLS polymerase takes the place of the replicative polymerase, thus allowing the TLS 
polymerase to incorporate a nucleotide across from the lesion. The second switch occurs 
once the lesion is bypassed: the replicative polymerase comes back on to the chromatin, 
and DNA synthesis resumes.  
The mechanisms by which the “switches” occur are not well understood. One way 
that Y polymerases may be regulated is by ubiquitylation. In budding yeast, levels of the 
POLH homolog Rad30 fluctuate in response to UV treatment. Although the ubiquitin 
machinery involved has not yet been identified, data suggest that Rad30 undergoes 
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ubiquitin-mediated proteolysis when it is not needed (i.e. in the absence of DNA damage) 
and is stabilized after UV treatment (Skoneczna et al., 2007). In mammalian cells, levels 
of POLH have also been shown to change in response to cellular stress. The E3 ligase 
Pirh2 may play a role in regulating POLH protein levels, although promotion of 
ubiquitin-mediated proteolysis by this E3 ligase has not been shown (Jung et al., 2010). 
Mammalian POLH has also been shown to be monoubiquitylated in the absence of 
damaged DNA (Bienko et al., 2010). As with other reports on Y polymerase regulation, 
the machinery that regulates this modification has not been reported, and the authors of 
this work even suggest that the monoubiquitylation of POLH may be E3-independent. In 
all, it appears from the limited studies on the regulation of Y polymerases that they are 
posttranslationally modified, likely by an ubiquitylation event, to hold them inactive in 
the absence of DNA lesions. 
Although there is growing data in support of the polymerase-switching model, it 
is restricted to times of active DNA replication. The second model, the gap-filling model, 
has been proposed to account for the roles of TLS polymerases outside of DNA 
replication. In this model, TLS polymerases are recruited to stretches of single-stranded 
DNA (ssDNA) gaps and subsequently fill in the gaps by synthesizing across the lesion 
using the opposite DNA strand as a template (Waters et al., 2009). Evidence in support of 
the gap-filling model is currently restricted to S. cerevisiae, although it is possible that 
both polymerase switching and gap filling occur in all organisms depending on the lesion 
and the cell-cycle stage. 
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Figure 1.3. Translesion synthesis (TLS). TLS is defined by the replicative bypass of 
DNA damage. This process is mediated by PCNA and its recruitment of members of the 
Y family of DNA polymerases, consisting of Rev1, Polι, Polη and Polκ. One model 
proposed to explain the mechanism of lesion bypass at the replication fork is polymerase-
switching. The first switch occurs when the TLS polymerase takes the place of the 
replicative polymerase (Polδ or Polε), thus allowing the TLS polymerase to incorporate a 
nucleotide across from the lesion. The second switch occurs once the lesion is bypassed; 
the replicative polymerase is recruited back to the chromatin, and normal DNA synthesis 
resumes. 
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THE ROLE OF Y-FAMILY DNA POLYMERASES IN CAENORHABDITIS 
ELEGANS EMBRYOGENESIS 
Although little has been reported on potential roles for the Y-family polymerases 
or TLS during development, mRNA expression data sets show that Y-family polymerases 
are highly expressed during gametogenesis and embryogenesis of many developing 
organisms. Similar to Drosophila, early embryonic cell cycles of C. elegans are rapid and 
maternally controlled (Bao et al., 2008). Knockdown of polh-1, the C. elegans DNApol-
eta homolog, in the female germ line results in increased sensitivity of early embryos to 
UV radiation (Ohkumo et al., 2006). This finding suggests that POLH-1, and perhaps 
TLS, plays a critical role during early embryogenesis in worms. POLH-1 has been further 
proposed to prevent stalling of replication forks during the early embryonic cell cycles of 
C. elegans by quickly responding to and bypassing lesions (Holway et al., 2006; Kim and 
Michael, 2008). The authors hypothesize that POLH-1 takes the place of replicative 
polymerases during S phase (via a polymerase-switching event) at this developmental 
stage, thereby keeping the rapid early embryonic cell cycles progressing on schedule.  
C. elegans POLH-1 has been shown to be modified by sumoylation via the 
SUMO E3 GEI-17 and by ubiquitylation via the Cul4-Ddb1-Cdt2 (CRL4-Cdt2) ubiquitin 
ligase (Kim and Michael, 2008). While these results suggest that sumoylation positively 
regulates POLH-1 by protecting it from degradation, modification of POLH-1 by 
ubiquitylation presumably occurs once POLH-1 has successfully bypassed the lesion to 
prevent the polymerases from binding to chromatin. Although ubiquitylation or ubiquitin-
mediated proteolysis by CRL4-Cdt2 has not specifically been shown, levels of POLH-1 
are stabilized when cdt-2 is knocked down in the C. elegans embryo.  
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In conclusion, there appears to be a unique role for the Y-family DNA 
polymerases during early embryonic cell cycles. Precise regulation of POLH-1 during C. 
elegans embryogenesis may be important to keep the rapid cycles on schedule, as well as 
to keep it away from the chromatin when it is not needed. These data support a highly 
regulated polymerase-switching model of the replicative and Y-family DNA polymerases 
during S phase of developing embryos. Given that expression of the Y polymerases 
during early embryogenesis is highly conserved in eukaryotes, it seems likely that these 
polymerases play important roles during this developmental window in other organisms. 
In the following chapters, I will present my work analyzing the roles of NOPO 
(No Poles) in the regulation of Drosophila early embryogenesis and genome 
maintenance. I will also present my work investigating interactors of NOPO’s 
mammalian homolog, TRIP (TRAF-interacting protein). My identification and 
characterization of NOPO and TRIP as E3 ubiquitin ligases should provide critical 
insight into the mechanisms underlying cell-cycle progression and genome maintenance. 
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CHAPTER II 
 
no poles ENCODES A PREDICTED E3 UBIQUITIN LIGASE 
REQUIRED FOR EARLY EMBRYONIC DEVELOPMENT OF 
DROSOPHILA 
 
The contents of this chapter have been published (Merkle et al. 2009). 
 
INTRODUCTION 
To ensure faithful transmission of the genome upon cell division, eukaryotic cells 
have developed checkpoints, regulatory pathways that delay cell-cycle progression until 
completion of prior events. The DNA damage/replication checkpoint plays a critical role 
in preserving genomic integrity (Branzei and Foiani, 2008). Upon detection of DNA 
defects, the kinases ATM (ataxia telangiectasia mutated) and ATR (ATM-Rad3-related) 
are recruited to sites of damage and activated. ATM and ATR substrates include 
checkpoint kinases Chk1 and Chk2, which phosphorylate proteins that mediate cell-cycle 
arrest. The ensuing delay, resulting from engagement of this checkpoint, presumably 
allows cells time to correct defects.  
Research over the past decade has highlighted major roles for protein 
ubiquitination in regulating cellular responses to DNA damage (Harper and Elledge, 
2007). This post-translational modification, which involves covalent linkage of one or 
more ubiquitin molecules to another protein, regulates many fundamental cellular 
processes (Pickart, 2001). Ubiquitination may alter a protein’s fate in numerous ways, 
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such as targeting it for destruction by the 26S proteasome, changing its subcellular 
location, or changing its protein-protein interactions.  
Ubiquitination is a highly dynamic, multi-step process that requires three 
components: ubiquitin activating enzyme (E1), ubiquitin conjugating enzyme (E2 or 
Ubc), and ubiquitin ligase (E3). E3s can be divided into two main classes: HECT and 
RING domain-containing proteins. RING-type E3 ubiquitin ligases (Freemont, 2000; 
Jackson et al., 2000) contain a specialized motif of 40 to 60 residues that binds two zinc 
atoms. Many RING-type E3s bind to partnering E2 conjugating enzymes via their RING 
domains (Passmore and Barford, 2004). Database searches of the Drosophila genome 
predict that it contains one E1, 36 E2s, and ~130 E3s, which represents ~40% of the 
ubiquitination machinery in humans (Ditzel and Meier, 2005). 
Significant insights into the roles of many cell-cycle regulators have come from 
studying their functions in Drosophila. Drosophila is well suited for studying cell-cycle 
regulation during formation of a multicellular organism, in large part due to its 
developmental use of cell cycles differing in structure from canonical G1-S-G2-M cycles 
and availability of genetic tools (Garcia et al., 2007; Lee and Orr-Weaver, 2003). The 
first thirteen cell cycles of Drosophila embryogenesis involve nearly synchronous nuclear 
divisions driven by stockpiles of maternally expressed mRNA and protein (Foe et al., 
1993). These rapid cycles (~ten minutes in length) consist of oscillating S-M (DNA 
replication-mitosis) phases without intervening gap phases or cytokinesis. Minimal gene 
transcription occurs during this developmental stage, so cell cycles are regulated by post-
transcriptional mechanisms. At cycle 14, the embryo cellularizes and initiates zygotic 
transcription at the midblastula transition (MBT).  
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We report here the identification and characterization of a Drosophila maternal-
effect lethal mutant that we have named “no poles” (“nopo”). Embryos from nopo 
females undergo mitotic arrest with acentrosomal, barrel-shaped spindles during syncytial 
divisions. Our results indicate this arrest is secondary to activation of a Chk2-mediated 
DNA checkpoint in early embryos. We show that NOPO, a predicted E3 ubiquitin ligase, 
interacts with an E2 component, BEN. ben females are sterile, producing embryos with 
nopo-like defects. We propose that BEN-UEV1A and NOPO function together as an E2-
E3 complex required for genomic integrity during Drosophila embryogenesis.  
 
RESULTS 
 
The nopo phenotype in the early embryo 
We previously screened the maternal-effect lethal subset of the Zuker collection 
to identify genes that regulate S-M cycles of Drosophila early embryogenesis 
(Koundakjian et al., 2004; Lee et al., 2003; Rickmyre et al., 2007). We identified an allele 
(Z1447) of a gene that we have named "no poles" (nopo) based on the phenotype of 
acentrosomal mitotic spindles in mutant-derived embryos (see below). nopoZ1447 females 
are completely sterile (Table 2.1). DNA staining of egg chambers of nopoZ1447 females 
revealed no obvious oogenesis defects, and the presence of polar bodies in their 
unfertilized eggs indicated that meiosis was completed (data not shown). 
We found that nopoZ1447-derived embryos undergo mitotic arrest during syncytial 
divisions with none developing to cellularization or gastrulation (Tables 2.1,2.2; data not 
shown). Nuclei are unevenly spaced (compare Fig. 2.1B to A), and centrosome 
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Table 2.1. nopo allelic series and transgenic rescue 
Temperature 
(˚C) 
 
Genotype 
Cortical 
(%)a 
Gastrulation 
(%)b 
Hatch 
rate (%) 
25 Wild type 92 91 89 
 nopoSZ3004 62 65 12 
 nopoSZ3004/Df(2R)Exel7153 67 12   0 
 nopoZ1447 72   0   0 
 nopoZ1447/Df(2R)Exel7153 68   0   0 
 pCaSpeR4-CG5140/+; nopoZ1447 95 92 87 
 nopoExc142 15   0   0 
 nopoExc142/Df(2R)Exel7153   7   0   0 
 pCaSpeR4-CG5140/+; nopoExc142 93 90 83 
18 Wild type 97 97 89 
 nopoSZ3004 78 86 76 
 nopoZ1447 67   1   0 
Embryos collected from females of the indicated genotypes were fixed for DNA and tubulin staining (see 
methods for details). 
aPercent of embryos that develop to cycle 10 or beyond. For each genotype, at least 200 embryos  (2-2.5 hour) 
were scored. 
bPercent of embryos that develop to initiation of gastrulation or beyond. For each genotype, at least 200 
embryos (3-4 hour) were scored. 
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duplication before telophase is occasionally evident (Fig. 2.1F), both consistent with 
failed mitotic divisions. nopo spindles are barrel-shaped, lack tubulin foci, and have 
misaligned chromosomes (Fig. 2.1D-F; Table 2.2); lack of tubulin foci correlates with 
loss of centrosomes at the poles as revealed by staining for Centrosomin, a core 
component (Fig. 2.1I,J; Li and Kaufman, 1996). ~10% of nopo spindles are tripolar (Fig. 
2.1K; Table 2.2). Bipolar nopo spindles often appear wider and to contain more than the 
wild-type complement of chromosomes (compare Fig. 2.1E and C). Similar results were 
obtained for nopoZ1447 in trans to Df(2R)Exel7153, which deletes nopo (Table 2.1). 
 
nopo encodes a RING domain-containing protein 
We identified CG5140 as the nopo gene using a combination of genetic mapping and 
molecular biology approaches (Fig. 2.2A; see methods for details). A wild-type copy of 
CG5140 carried as a transgene fully restored fertility to nopo females (Table 2.1), 
confirming that CG5140 is, indeed, the nopo gene. nopo encodes a predicted protein of 
435 amino acids containing an N-terminal RING domain (Fig. 2.2B; Saurin et al., 1996). 
The putative mammalian homolog of NOPO was named "TRAF-interacting protein 
(TRIP)" based on its ability to bind tumor necrosis factor (TNF) receptor-associated 
factors (TRAFs) (Lee et al., 1997). Mammalian TRIP was recently demonstrated to have 
RING-dependent E3 ubiquitin ligase activity in an auto-ubiquitination assay (Besse et al., 
2007).  Drosophila NOPO and human TRIP are 20% identical and 34% similar overall 
with 47% identity and 65% similarity in their RING domains. Importantly, nopoZ1447 
causes a glutamic acid to lysine change in the RING domain at position 11 of the  
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Table 2.2. The nopo phenotype is suppressed by mnk 
 
 
 
Genotype 
 
 
 
M.I.a 
Mitotic spindle defects (%Spindles)b  
 
Gastrulation 
(%Embryos)e 
 
Hatch 
rate 
(%) 
Bipolar  spindles  
Tripolar 
spindles 
Abnormal centrosome# Barrel- 
Shaped Decreasedc Increasedd 
Wild type 0.63 <1   0 <1 <1 100 89 
nopoZ1447 0.95 62 13 64 10    0   0 
mnk6006 0.64   1 <1   1 <1  99 80 
mnk6006 nopoZ1447 0.68 <1 <1 <1 <1  77   0 
Embryos collected from females of the indicated genotypes were used to determine hatch rates or were fixed for DNA and tubulin 
staining (see methods for details). 
aMitotic Index (M.I.) = %Embryos in mitosis/Total number of embryos. >300 embryos were scored per genotype. Chromosome 
condensation and the presence of a mitotic spindle were used as the criteria for mitosis. 
bAll mitotic spindles (>500 total) in a single focal plane were scored using at least 25 embryos per genotype.  
cSpindles with centrosomal detachment at one or both poles. 
dSpindles with >1 centrosome per pole (one or both poles). Telophase spindles were not scored because centrosome duplication occurs 
during this phase in the early embryo.  
eStained embryos (3-4 hours) were scored for development to initiation of gastrulation (or beyond). >200 embryos were scored per 
genotype.
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Figure 2.1. The nopo phenotype. Representative syncytial embryos and mitotic spindles 
in embryos from wild-type or nopoZ1447 females. (A,B) Staining of nopo-derived embryos 
reveals developmental arrest with condensed, unevenly spaced DNA (B) compared to 
wild type (A). (C-G) Microtubules are in green and DNA in red. (C) Wild-type spindle. 
(D-F) Shortened, barrel-shaped nopo spindles with detached centrosomes and misaligned 
chromosomes. Arrowheads, detached centrosomes out of focal plane; arrow, DNA at 
pole. Metaphase-like spindle with two centrosomes per pole (F) reveals asynchrony of 
nuclear and centrosome cycles. (G) Similar defects in nopoExc142/Df(2R)Exel7153-derived 
embryo. (H-K) Microtubules are in green and centrosomes in blue. (H) Wild-type 
spindle. (I,J) nopo spindles with detached and/or missing centrosomes. (K) Tripolar nopo 
spindle. Bars, 20 µm. 
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Figure 2.2. CG5140 is the nopo gene. (A) nopo structure. Coding regions are 
represented by black boxes, 5’- and 3’-UTRs by white boxes, splicing events by lines. 
Arrows indicate transcription direction. Asterisk marks position of E11K mutation in 
nopoZ1447. Triangles represent P-elements. EYG5845 imprecise excision generated 
nopoExc142 (gap represents deleted region). Dashed line represents genomic region used to 
create rescue construct. (B) Comparison of Drosophila NOPO and human TRIP. Gray 
boxes represent RING domains. Asterisk marks mutation in nopoZ1447. Line indicates 
NOPO region used for antibody production. (C) Alignment of RING domains of putative 
NOPO/TRIP homologs in Drosophila melanogaster, Homo sapiens, Mus musculus, 
Danio rerio, Gallus gallus, and Anopheles gambiae. Residues 6-46 of Drosophila NOPO 
are shown. Critical RING-domain cysteines and histidines are highlighted. Asterisk 
marks residue mutated in nopoZ1447. (D,E) NOPO immunoblots. (D) NOPO levels in 
embryos (1-2 hours) of wild-type or nopo females. Anti-NOPO antibodies recognize 
specific band of NOPO's predicted size (48 kDa) and non-specific band (bg). (E) NOPO 
developmental Western. Loading control: anti-GAPDH or anti-α-tubulin. 
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predicted protein, a residue that is invariantly negatively charged across species (Fig. 
2.2C). 
 
nopo is maternally provided and essential solely in the early embryo 
To gain further insights into nopo’s functions, we obtained additional alleles. 5-
SZ-3004 (abbreviated as SZ3004) and EYG5845 are P-element insertions in the 5’-UTR 
of nopo (Fig. 2.2A). nopoSZ3004 females have decreased embryonic hatch rates that are 
completely restored by precise P-element excision (Table 2.1; data not shown). nopoSZ3004 
is weaker than nopoZ1447 based on the percentage of mutant-derived embryos that develop 
to gastrulation and embryonic hatching, and its phenotype is strongly temperature-
dependent. We generated a null allele of nopo (Exc142) via imprecise excision of 
EYG5845 (Fig. 2.2A; see methods). nopoExc142 adults are viable and appear normal except 
that females are sterile, producing embryos with the nopo phenotype (Fig. 2.1G); a 
CG5140 transgene fully restored fertility (Table 2.1). nopoExc142 is stronger than nopoZ1447 
with 15% versus 72%, respectively, of their embryos reaching cortical divisions, 
suggesting that nopoZ1447 has residual function. 
We assessed NOPO levels in mutant embryonic extracts by immunoblotting using 
anti-NOPO antibodies that we generated (Fig. 2.2D). Consistent with NOPO’s predicted 
size (435 residues), these antibodies recognize a ~48 kDa band in wild-type embryos that 
is absent in nopoExc142-derived (null) embryos. NOPO was not detected in nopoSZ3004-
derived embryos, although we occasionally observe trace amounts (data not shown). 
Wild-type levels of NOPO were found in nopoZ1447-derived embryos, suggesting that the 
E11K mutation alters NOPO’s function, but not its stability.  
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We assessed NOPO levels throughout Drosophila development (Fig. 2.2E). 
NOPO is abundant in ovaries and early (0-3 hour) embryos; trace amounts are present in 
older (3-24 hour) embryos. We did not detect NOPO in larval brains, imaginal discs, 
testes, or adult carcasses lacking germline tissues. Subsequent experiments, however, 
revealed roles for NOPO outside of early embryonic development, suggesting that our 
antibodies might not be sufficiently sensitive to detect its expression during other stages 
(see below). Using the UAS/Gal4 system, we found NOPO overexpression in the female 
germline causes severely reduced egg-laying and hatch rates, whereas broad 
overexpression of NOPO in somatic cells causes lethality, suggesting that NOPO levels 
must be tightly regulated (data not shown). 
 
The nopo phenotype is suppressed by mutation of the checkpoint kinase MNK 
(Chk2)  
In Drosophila syncytial embryos, mitotic entry with incompletely replicated or 
damaged DNA triggers a Chk2-mediated protective mechanism known as centrosomal 
inactivation (Sibon et al., 2000; Takada et al., 2003). This damage-control system senses 
DNA defects and elicits localized changes in spindle structure that block mitotic 
progression, presumably to prevent propagation of defective DNA. We previously 
reported that embryos from microcephalin (mcph1) females arrest in mitosis with 
acentrosomal, barrel-shaped spindles similar to those that we now observe in nopo-
derived embryos (Rickmyre et al., 2007). We demonstrated that these mcph1 defects 
were suppressed by mutation of maternal nuclear kinase (mnk), also known as loki, 
which encodes Drosophila Chk2 (Abdu et al., 2002; Brodsky et al., 2004; Masrouha et 
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al., 2003; Xu et al., 2001). mnk nulls exhibit increased sensitivity to ionizing radiation but 
are viable and fertile. Suppression of mcph1 by mnk revealed that centrosomal 
inactivation significantly contributes to the mcph1 phenotype. 
To determine if the mitotic defects of nopo-derived embryos are, like those of 
mcph1, due to Chk2-mediated centrosomal inactivation, we created lines doubly mutant 
for nopo and mnk. The nopo phenotype of acentrosomal, barrel-shaped mitotic spindles 
was strongly suppressed by mnk as evidenced by restoration of normal spindles with 
attached centrosomes (Fig. 2.3A-C; Table 2.2). DNA defects, however, are common in 
embryos from mnk nopo females, particularly during cortical divisions. We frequently 
observe abnormal DNA aggregates, some of very large size, shared by more than one 
spindle (Fig. 2.3D,E).   
Like mcph1, we found that the developmental arrest of nopo mutants is 
suppressed by mnk (Fig. 2.3F,G; Table 2.2). In contrast to nopo-derived embryos, which 
arrest in syncytial divisions, most embryos from mnk nopo females complete syncytial 
divisions, cellularize, and arrest with aberrant morphology upon initiation of gastrulation. 
Cellularized embryos from mnk nopo females contain unusually large DNA masses 
within irregularly sized cells compared to wild type. Thus, mnk suppresses the 
spindle/centrosomal defects and developmental arrest of nopo mutants, but DNA defects 
appear to accumulate.   
Based on these findings, we propose that nopo is required for preservation of 
genomic integrity during syncytial embryogenesis. Lack of nopo activity leads to 
occurrence of DNA defects, which then trigger Chk2-mediated centrosomal inactivation, 
thereby causing widespread mitotic arrest and blockade of embryonic development. 
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Figure 2.3. Suppression of nopo by mnk. (A-E) Representative mitotic spindles in 
syncytial embryos from wild-type (A), nopoZ1447 (B) and mnk nopoZ1447 females (C-E). (A-
C) Microtubules are in green, DNA in red, and centrosomes in blue. nopo (B) is 
suppressed by mnk as evidenced by restoration of elongated spindles with attached 
centrosomes (C). (D,E) Microtubules are in green and DNA in red. Aberrant mitotic 
figures with DNA shared by two spindles in mnk nopo-derived embryos. (F,G) 
Cellularized embryos (2-3 hours). Actin is in green and DNA in red. Developmental 
arrest of nopo is suppressed by mnk. Cellularized mnk nopoZ1447-derived embryos with 
large DNA masses (G) compared to wild type (F). Bars, 10 µm (A-E) or 20 µm (F,G).  
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Mutation of mnk (Chk2) allows further nuclear divisions and developmental progression 
in nopo-derived embryos despite accumulation of extensive DNA defects that eventually 
lead to their arrest at the onset of gastrulation. 
 
nopo-derived embryos exhibit decreased interphase length  
 The DNA-replication checkpoint mediated by MEI-41 and Grapes, orthologs of 
ATR and Chk1, respectively, is developmentally activated in late syncytial embryos of 
Drosophila (Sibon et al., 1999; Sibon et al., 1997). Checkpoint activation, which may be 
triggered by titration of a maternal replication factor, leads to inhibitory phosphorylation 
of Cdk1 and gradual slowing of mitotic entry, presumably to allow sufficient time to 
complete DNA replication. At MBT (cycle 14), the first G2 gap phase is introduced. 
Embryos from mei-41 or grapes (grp) females fail to lengthen interphases of late 
syncytial cycles and are thought to enter mitosis without completing DNA replication; a 
secondary damage-control system, Chk2-mediated centrosomal inactivation, then 
becomes operational (Sibon et al., 2000; Takada et al., 2003). 
 Mitotic entry with incompletely replicated DNA can cause Chk2-mediated 
centrosomal inactivation in syncytial embryos (Sibon et al., 2000; Takada et al., 2003). 
Control mechanisms to ensure completion of DNA replication prior to mitosis may be 
particularly critical during rapid S-M cycles. Oscillating Cdk1-Cyclin B activity plays a 
key role in coordinating these cycles (Edgar et al., 1994; Su et al., 1998). S-M transitions 
appear to be controlled by Cyclin B levels prior to cycle 10 and by both Cyclin B levels 
and a DNA-replication checkpoint in cycles 10-13 (Ji et al., 2004; Sibon et al., 1997).  
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Using a previously described approach, we monitored timing of nuclear envelope 
breakdown and reformation in cycles 11-13 by differential interference contrast (DIC) 
microscopy to test whether nopo mutants, like mei-41 and grp, fail to lengthen interphase 
(Fig. 2.4; Rickmyre et al., 2007; Takada et al., 2007). Live imaging of nopo-derived 
embryos during cortical divisions was not feasible because the majority arrest either 
before or during these cycles (Table 2.1; data not shown); yolk proteins obscure the 
interior nuclei of precortical embryos, making imaging of these earlier divisions 
technically difficult. We analyzed timing of cortical cell cycles in embryos from mnk 
nopo females (lacking a Chk2-mediated checkpoint) because they develop further than 
nopo-derived embryos; we reasoned that primary defects in cell-cycle kinetics due to 
nopo mutation would still be apparent. In support of this line of reasoning, embryos from 
mnk grp females have been shown to retain the cell-cycle timing defects of grp-derived 
embryos (Takada et al., 2007). Embryos from mnk nopoZ1447 females exhibited 
significantly shorter interphases during cycle 11 (mean of 3.3 minutes) compared to wild 
type or mnk (4.8 or 5.4 minutes, respectively; Fig. 2.5A,B). Essentially identical results 
were obtained for mnk nopoZ1447/Df(2R)Exel7153 and mnk nopoZ1447/nopoExc142 females. 
Importantly, interphase 11 length was restored by transgenic rescue. A shortened 
interphase 11 (2.7 minutes) was observed in grp-derived embryos, as expected. Unlike 
grp, however, mnk nopo-derived embryos exhibited normal cycle 12 and 13 interphase 
lengths.  
Based on our observations of shorter cycle 11 interphases in mnk nopo-derived 
embryos, we infer that interphases of earlier (precortical) syncytial cycles may be 
relatively short in nopo-derived embryos. We hypothesize that DNA replication is not 
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Figure 2.4. Cell-cycle timing of syncytial blastoderm divisions. Representative still 
DIC micrographs from an imaging sequence of a wild-type embryo illustrate the criteria 
used to score the onset of interphase and mitosis. Nuclear envelope "rings" (arrowheads) 
are readily visible at the cortex of the embryo during interphase but not mitosis. (A) 
Nuclear envelope formation (NEF) marks the onset of interphase 11. (B) Nuclear 
envelope breakdown (NEB) marks the onset of mitosis 11. (C) NEF marks the onset of 
the following interphase 12. Images were captured at 20-second intervals and cell-cycle 
timing determined by counting frame numbers between NEF and NEB. Timing data were 
independently validated by a second observer. Strict temperature control (22.0±0.5°C) 
was maintained throughout the experiment as monitored by a sensor on the microscope 
stage; wild-type and mutant embryos were alternately analyzed in every recording 
session as further control. Time (s, seconds) elapsed from the onset of cycle 11 is 
indicated for each micrograph. Bars, 10 µm. 
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Figure 2.5. Shortened cycle 11 interphase of mnk nopo-derived embryos. (A,B) Cell-
cycle timing during cortical embryonic divisions. Bar graph (A) shows mean cycle 11 
interphase lengths for various genotypes. Table (B) summarizes mean cycle 11-13 
interphase (I) and mitosis (M) lengths. n, number of embryos. Error bars (A) and ± values 
(B) represent s.e.m. Single and double asterisks mark interphases significantly shorter 
than wild type (P-value<0.01 and <0.001, respectively). (C,D) Immunoblotting reveals 
normal pY15-Cdk1 (C) and Cyclin B (D) levels in mnk nopoZ1447-derived embryos (1-2 
hours). Control grp-derived embryos have reduced pY15-Cdk1. Loading control: anti-α-
tubulin or anti-GAPDH. 
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completed during these truncated interphases, resulting in mitotic entry with unreplicated 
DNA, triggering of Chk2-mediated centrosomal inactivation, and mitotic arrest with 
failure of further embryonic development.  
Most embryos from nopo-null females arrest prior to the onset at cycle 11 of a 
detectable DNA-replication checkpoint effect (Table 2.1; Crest et al., 2007). Thus, we 
reasoned that nopo is unlikely to regulate interphase length via mei-41/grp. Nonetheless, 
we tested intactness of the MEI-41/GRP-mediated DNA-replication checkpoint by 
assessing levels of Cdk1 inhibitory phosphorylation in mnk nopo-derived embryos and 
found them to be comparable to wild type (Fig. 2.5C). We also observed an intact DNA 
damage response by nopo larvae treated with hydroxyurea, a DNA replication inhibitor, 
or irradiation (Table 2.3). We observed no genetic interactions between nopo and mei-41 
(data not shown). We detected wild-type levels of Cyclin B and Cyclin A in mnk nopo-
derived embryos and observed no genetic interactions between nopo and cyclin B (Fig. 
2.5D; data not shown). These results suggest that nopo regulates the S-M transition 
independent of the MEI-41/GRP-dependent checkpoint and mitotic cyclin levels. 
 
Drosophila NOPO and human TRIP co-localize to nuclear puncta in cultured 
mammalian cells 
To determine the subcellular localization of NOPO, we used transfected 
mammalian cells because our anti-NOPO antibodies did not work for 
immunofluorescence, and epitope-tagged forms of NOPO expressed via transgenesis 
were not stable in Drosophila embryos (data not shown). We transfected HeLa cells with 
fluorescently tagged versions of Drosophila NOPO and human TRIP (candidate homolog  
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Table 2.3. Survival of nopo larvae after hydroxyurea treatment or irradiation 
 
Genotype 
Percent homozygotesb  Percent eclosionc 
-HU +HU  0 Gray 10 Gray 
mei-41RT1 62 (557) 3 (235)  82 (170) 3 (177) 
nopoZ1447 34 (562) 35 (587)  86 (107) 87 (112) 
nopoExc142 n.d.a n.d.  92 (149) 88 (129) 
nopoZ1447/Df(2R)Exel7153 n.d. n.d.  98 (124) 89 (128) 
nopoExc142/Df(2R)Exel7153 35 (440) 31 (397)  92 (210) 97 (167) 
nopoZ1447/ nopoExc142 n.d. n.d.  99 (147) 99 (192) 
an.d., not determined. 
bSensitivity to hydroxyurea (HU). First instar larvae were grown on food minus or 
plus HU and allowed to develop. For each genotype, the ratio of homozygous 
mutant to total progeny is expressed as a percentage with total number of adult 
flies scored shown in parentheses. Expected percentages (based on Mendelian 
ratios) were 50% and 33% for mei-41 and nopo, respectively. 
cSensitivity to irradiation. Third instar larvae were untreated or exposed to low-
dose irradiation and allowed to develop. For each genotype, the ratio of eclosed 
adults to total pupae is expressed as a percentage with total pupae shown in 
parentheses.  
 47 
of NOPO) and assessed their localizations by immunofluorescence microscopy. Whereas 
eGFP (control) is homogeneously distributed, eGFP-NOPO localizes to nuclear puncta in 
a majority of interphase cells (compare Fig. 2.6A to B); a similar pattern was observed 
for Myc-tagged NOPO (data not shown). mCherry-TRIP also exhibited a punctate 
distribution in nuclei (Fig. 2.6D). Co-expression of eGFP-NOPO and mCherry-TRIP in 
HeLa cells confirmed their essentially identical localization patterns, underscoring the 
likelihood that NOPO and TRIP are functional homologs (Fig. 2.6C-E).  
CREST staining of HeLa cells expressing eGFP-NOPO revealed that 
NOPO/TRIP localizes to nuclear regions distinct from centromeres. To assess whether 
eGFP-NOPO localizes to nuclear puncta in a cell cycle-dependent manner, we 
immunostained transfected HeLa cells for PCNA or Cyclin A. We found that >99% of 
cells positive for eGFP-NOPO puncta were negative for insoluble PCNA foci in the 
nucleus, a marker of S-phase (Somanathan et al., 2001). In contrast, ~97% of cells 
positive for eGFP-NOPO puncta were positive for nuclear Cyclin A, a marker of both S 
and G2 phases (Girard et al., 1991). Taken together, these data indicate that eGFP-NOPO 
specifically localizes to nuclear puncta in transfected HeLa cells during G2 phase.  
 
NOPO associates with BEN, an E2 heterodimer component 
The presence of a RING domain in NOPO suggested that it might function as an 
E3 ubiquitin ligase (Lorick et al., 1999). In a high-throughput yeast two-hybrid screen 
(Giot et al., 2003), NOPO interacted with an E2 ubiquitin-conjugating enzyme, Bendless 
(BEN), the Drosophila homolog of Ubc13 (Muralidhar and Thomas, 1993; Oh et al., 
1994; Zhou et al., 2005). 
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Figure 2.6. Nuclear localization of NOPO. Immunofluorescence microscopy of 
transfected HeLa cells. DNA is in blue. (A,B) eGFP is in green and actin in red. eGFP-
Drosophila NOPO (B) localizes to nuclear puncta; eGFP (A) is homogeneously 
distributed. (C-E) eGFP is in green and mCherry in red. eGFP-Drosophila NOPO (C) and 
mCherry-human TRIP (D) co-localize in nuclear puncta (E, merge). (F-H) eGFP is in 
green and CREST in red. eGFP-NOPO (F) is not at centromeres (G) (H, merge). (I) Cells 
with GFP-NOPO puncta (green) are negative for PCNA puncta (red). (J) Cells with GFP-
NOPO puncta (green) are positive for nuclear Cyclin A (red). Bars, 10 µm. 
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To confirm and extend these observations, we tested for interactions between 
combinations of wild-type and mutant NOPO and BEN proteins in a yeast two-hybrid 
assay (Fig. 2.7A). We used mutant NOPO and BEN forms encoded by nopoZ1447 (E11K in 
the RING domain; Fig. 2.2A-C) and ben1 (proline to serine change at position 97; 
Muralidhar and Thomas, 1993). We found that both wild-type and mutant NOPO self-
interacts in this assay. When used as bait, wild-type BEN strongly interacts with wild-
type NOPO; we occasionally observe weak interaction in the reverse direction (data not 
shown). In contrast, wild-type BEN and mutant NOPO do not interact, and mutant BEN 
interacts only marginally with wild-type or mutant NOPO.  
We detected comparable levels of mutant and wild-type fusion proteins (both 
NOPO and BEN) in transformed yeast. Furthermore, nopoZ1447-derived embryos have 
wild-type NOPO levels, and ben1 ovaries have wild-type BEN levels (Fig. 2.2D; data not 
shown). Thus, lack of two-hybrid interactions observed for mutant NOPO and BEN 
likely reflects changes in protein-protein interactions rather than decreased stability.  
To obtain further evidence that NOPO and BEN interact, we compared the localization 
patterns of fluorescently tagged versions of these proteins in transfected HeLa cells. Both 
eGFP-NOPO and mCherry-TRIP accumulate in nuclear puncta (Figs. 2.6E, 2.7C). When 
transfected alone, eGFP-BEN distributes throughout cells with a perinuclear 
concentration but no obvious nuclear puncta (Fig. 2.7B). When eGFP-BEN and mCherry-
TRIP were co-transfected, however, eGFP-BEN localized to nuclear puncta in the 
majority (56%) of cells positive for mCherry-TRIP nuclear puncta; furthermore, all 
puncta positive for eGFP-BEN were positive for mCherry-TRIP (Fig. 2.7D-F). These  
 50 
 
Figure 2.7. NOPO/TRIP, BEN, and UEV1A interactions and co-localization. (A) 
Yeast two-hybrid assay. Yeast cells expressing combinations of NOPO, BEN, and 
UEV1A fused to Gal4 DNA binding domain (BD, “bait”) or activation domain (AD, 
“prey”) were spotted onto selective media. Growth on SC-Trp-Leu-His media (shown) 
indicates physical interaction between fusion proteins. Wild-type and mutant versions of 
NOPO and BEN (E11K and P97S, respectively) were tested. A representative plate 
spotted in duplicate is shown; identical results were obtained for three independent 
Trp+Leu+ colonies per plasmid combination tested. (B-F) Immunofluorescence 
microscopy of transfected HeLa cells. eGFP-BEN is in green, mCherry-TRIP in red, and 
DNA in blue. eGFP-BEN (C) and mCherry-TRIP (D) localize distinctly when transfected 
alone. (D-F) Co-transfection of eGFP-BEN (D) with mCherry-TRIP (E) promotes its 
localization into nuclear puncta (F, merge). Bars, 20 µm.  
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data suggest that NOPO/TRIP can recruit BEN/Ubc13 to chromatin and provide further 
evidence for in vivo interactions between these proteins. 
The E2 activity of Ubc13 has been shown in other systems to require 
heterodimerization with a UEV (ubiquitin-conjugating E2 enzyme variant) family 
member (Pickart, 2001). UEV proteins (Mms2p in budding yeast; Uev1A and Mms2 in 
mammals) resemble E2s but lack an active site cysteine (Broomfield et al., 1998; Sancho 
et al., 1998). Our BLAST searches revealed a single UEV homolog in Drosophila 
encoded by Uev1A. In our two-hybrid assay, UEV1A strongly interacted with wild-type 
and mutant BEN, but not with NOPO (Fig. 2.7A). Our attempts to detect BEN-NOPO 
complexes in Drosophila embryos were unsuccessful, however, possibly due to 
transience of this interaction (data not shown). Our yeast two-hybrid data suggest that 
NOPO's RING domain interacts directly with BEN to promote formation of a UEV1A-
BEN-NOPO (E2-E3) complex.  
 
ben-derived embryos have nopo-like defects 
ben was identified in a screen for Drosophila mutants with neuronal connectivity 
defects (Thomas and Wyman, 1982). Its yeast two-hybrid interaction with NOPO 
suggested that BEN might regulate embryonic development. We found that embryos 
from ben1 homozygotes or hemizygotes fail to develop, revealing a new function for ben 
(Table 2.4).  
Immunostaining of ben1-derived embryos revealed that they arrest early in 
syncytial development with a small number (1-8) of mitotic nuclei (Fig. 2.8; Table 2.4). 
Most (72%) ben1-derived embryos contain one acentrosomal spindle. In Drosophila 
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Table 2.4. Quantification of defects in ben-derived embryos  
 
 
Genotype M.I.a 
 
Hatch  
rate (%) 
#Nuclei/Embryo 
(%Embryos) 
 
nopo-like spindles 
(%Embryos)c 1 2-8 >8 
Wild type 0.63 89 - - - <1 
ben1 0.92  2b 72 12 16 80 
ben1/Df(1)KA10 0.80 0 40 43 17 50 
Embryos collected from females of the indicated genotypes were used to determine 
hatch rates or were fixed for DNA and tubulin staining (see methods for details). 
At least 50 stained embryos were analyzed per genotype. Eggs/embryos in which 
DNA and tubulin were not visualized by staining were excluded from analysis. 
aMitotic Index (M.I.) = %Embryos in mitosis/Total number of embryos. 
Chromosome condensation and the presence of a mitotic spindle were used as 
the criteria for mitosis. 
bFor ben1 homozygotes, only 100 embryos were scored for hatching due to low 
egg-laying rates. 
cEmbryos in which the majority of mitotic spindles were barrel-shaped and/or 
lacking centrosomes were scored as being "nopo-like." 
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females, meiotic spindles lack centrosomes, which are provided by sperm (Foe et al., 
1993). Several lines of evidence suggest that ben1 acentrosomal spindles are mitotic 
rather than meiotic. Their presence requires fertilization, and they are positioned deep 
within the egg interior where the first mitotic spindle resides (meiotic spindles are 
positioned near the cortex); furthermore, the presence of polar bodies indicates 
completion of meiotic divisions, and centrosomes are occasionally seen near the spindle 
(Fig. 2.8A-E; data not shown).  
The spindle defects of ben1-derived embryos strikingly resemble those of nopo 
mutants (compare Fig. 2.8H,I to G). ben1 spindles are often acentrosomal, barrel-shaped, 
variable in width, and have misaligned chromosomes; similar phenotypes were observed 
in ben1 hemizygotes (Fig. 2.8J,K; Table 2.4). We were unable to test whether Chk2-
mediated centrosomal inactivation causes mitotic arrest in ben-derived embryos because 
doubly homozygous adults were not viable. Taken together, the yeast two-hybrid 
interactions, co-localization, and similar mutant phenotypes that we have observed 
suggest that BEN-UEV1A and NOPO function together as an E2-E3 complex required to 
preserve genomic integrity during early embryonic development in Drosophila. 
 
Assessment of ben-mediated functions in nopo mutants 
Because a given E2 can act in concert with multiple E3 ubiquitin ligases (Pickart, 
2001), we sought to determine which of BEN’s activities are mediated by NOPO. We 
assayed our nopo mutants for four additional biological functions previously ascribed to 
BEN. The Drosophila giant fiber system (GFS) is a simple neural circuit that mediates an 
escape response to visual stimuli (Allen et al., 2006). Because ben is required for proper  
 54 
 
Figure 2.8. ben phenocopies nopo. Representative mitotic spindles in syncytial embryos 
from wild-type, nopo, and ben  females. (A-J) Microtubules are in green and DNA in red. 
(A-E) Single mitotic spindle and polar body in ben1-derived embryo. (A) Dashed line 
marks embryo outline. Arrowhead, detached centrosome out of focal plane. (B-E) 
Magnified images of polar body (B,C) and mitotic spindle (D,E) from A. (F-K) Mitotic 
spindles in embryos from wild-type (F), nopoZ1447 (G), ben1 (H,I), and ben1/Df(1)HA92 
(J,K) females. ben-derived embryos exhibit nopo phenotypes, including barrel-shaped, 
acentrosomal spindles and displaced DNA (I, arrow). (K) Microtubules are in green and 
centrosomes in blue. ben1/Df(1)HA92 spindle with detached centrosome (arrowhead). 
Bars, 20 µm (A) or 10 µm (B-K).  
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synaptic connectivity in the GFS, ben adults fail to elicit a normal jump response to a 
light-off stimulus (Thomas and Wyman, 1982; Thomas and Wyman, 1984). ben adults 
have also been reported to exhibit abnormalities in thoracic musculature and impaired 
mobility, and a role in innate immunity has been ascribed to ben (Edgecomb et al., 1993; 
Zhou et al., 2005). 
We assessed intactness of the GFS of nopo flies by testing their jump response to 
visual stimuli and found them to be defective like ben flies (Fig. 2.9A; Oh et al., 1994; 
Thomas and Wyman, 1982). Unlike ben, however, nopo flies exhibited normal mobility 
in a climbing assay and had normal sites of attachment of tergal depressor of the 
trochanter (TDT) thoracic muscles to the scutellum (Fig. 2.9B,C). We tested the innate 
immune responses of nopo and ben males and found that both exhibited slightly reduced 
levels of diptericin induction after infection (Fig. 2.9D). These results suggest that BEN 
and NOPO act as an E2-E3 complex that regulates GFS synapse formation and innate 
immunity, whereas BEN regulates mobility and muscle attachment sites via a different 
E3 ligase; thus, NOPO mediates a subset of BEN's functions.  
 
DISCUSSION 
We propose a model in which NOPO, a RING domain-containing protein, 
interacts with the BEN-UEV1A heterodimer to form a functional E2-E3 ubiquitin ligase 
complex required during syncytial embryogenesis for genomic integrity, cell-cycle 
progression, and continuation of development (Fig. 2.10). In the absence of NOPO, lack 
of ubiquitination of yet unidentified NOPO targets results in truncation of S-phase and/or 
spontaneous DNA damage. Mitotic entry with unreplicated and/or damaged DNA  
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Figure 2.9. NOPO mediates a subset of BEN’s functions. Wild-type, ben, and nopo 
males were compared using several assays. (A) Visually-mediated jump response assay. 
(B) Climbing assay. (C) Assessment of TDT muscle attachment sites. (D) Innate 
immunity assay. diptericin induction was measured after injection of buffer (white bars) 
or E. coli (black bars). Relish (Rel) flies with defective immune response were used as 
control. Df is Df(2R)Exel7153. Error bars represent s.e.m. Single, double, and triple 
asterisks represent P-values <0.05, <0.01, and <0.001, respectively. 
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triggers activation of a Chk2-mediated checkpoint that leads to changes in spindle 
morphology, mitotic arrest, and failure of nopo-derived embryos to develop to 
cellularization.  
We favor a model in which NOPO regulates timing of S-M transitions in 
syncytial embryos to ensure that S-phase is of sufficient length to allow completion of 
DNA replication prior to mitotic entry. Inhibition of DNA replication in syncytial 
embryos (e.g. via aphidicolin injection) leads to chromatin bridging in subsequent 
mitoses and Chk2 activation, both of which occur in nopo-derived embryos, presumably 
due to mitotic entry with unreplicated chromosomes (Raff and Glover, 1988; Takada et 
al., 2003). The mechanism by which NOPO coordinates S-M transitions is unknown. Our 
data suggest that nopo may alter timing of these transitions independent of Cdk1-
CyclinB, although localized changes in levels and/or activities of these regulators not 
detectable by immunoblotting of whole-embryo lysates could play a critical role. It is 
unclear why the MEI-41/GRP-dependent checkpoint, which appears to be functional in 
nopo-derived embryos, would not be sufficient to slow mitotic entry.  
The punctate nuclear localization observed for NOPO and its human homolog, 
TRIP, expressed in HeLa cells may indicate a direct role for these proteins in regulation 
of chromatin structure. Furthermore, the G2 phase-specific localization that we observe 
for NOPO/TRIP in transfected HeLa cells may be consistent with a role for NOPO in 
slowing S-M transitions in syncytial embryos; in the absence of nopo, embryos that enter 
mitosis prematurely would likely do so without finishing DNA replication due to a lack 
of gap phases. 
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Figure 2.10. Model for NOPO's function in the early embryo. See text for details. 
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An alternative explanation for Chk2 activation in nopo-derived embryos is that 
they might incur elevated levels of spontaneous DNA damage. Syncytial embryos are 
considered to be unusual in that they activate Chk2 but not Chk1 in response to DNA 
damaging agents (Fogarty, et al., 1997; Sibon et al., 2000; Takada et al., 2007). Thus, 
spontaneous DNA damage would not be predicted to elicit the MEI-41/GRP-mediated 
replication checkpoint but would cause Chk2-dependent centrosomal inactivation during 
mitosis. Such a model would be consistent with the apparent lack of activation of the 
MEI-41/GRP-dependent checkpoint in nopo-derived embryos although it would not 
explain why interphase 11 is shortened. 
We previously reported that syncytial embryos from microcephalin (mcph1) 
females undergo mitotic arrest with a phenotype similar to that described herein for nopo 
(Rickmyre et al., 2007). Like nopo, Chk2-mediated centrosomal inactivation causes 
mitotic arrest in embryos lacking mcph1. nopo and mcph1 are unique among maternal-
effect lethal mutants in which Chk2-mediated centrosomal inactivation has been reported 
(e.g. grp, mei-41, wee1) in that their phenotypes appear to be more severe: centrosomes 
typically detach from spindles, and mitotic arrest occurs earlier, during precortical 
syncytial divisions (Rickmyre et al., 2007; Sibon et al., 2000; Stumpff et al., 2004; 
Takada et al., 2003). The underlying defects in nopo and mcph1 mutants may be distinct, 
however, because mnk mcph1-derived embryos exhibit normal cycle 11 interphase 
length, which are truncated in mnk nopo-derived embryos (Rickmyre et al., 2007). 
Furthermore, we detect no genetic interaction between nopo and mcph1 (J.L. Rickmyre, 
J.A. Merkle, and L.A. Lee, unpublished).  
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Mammalian TRIP was identified in a yeast two-hybrid screen for tumor necrosis 
factor (TNF) receptor-associated factor (TRAF) interactors (Lee et al., 1997). TRAFs 
transduce signals from members of the tumor necrosis factor (TNF)/tumor necrosis factor 
receptor (TNFR) superfamily, which elicit diverse cellular responses in the immune and 
inflammatory systems (Hehlgans and Pfeffer, 2005). TRIP has been reported to inhibit 
TRAF2-mediated NF-kB activation; the RING domain of TRIP, however, was not 
required for inhibition (Lee et al., 1997). In contrast, our analysis of nopoZ1447 indicates 
that this motif is essential for NOPO function in Drosophila embryogenesis, likely by 
mediating its interactions with E2 components as has been shown for other E3 ligases 
(Passmore and Barford, 2004). Drosophila Eiger (TNF ligand) and Wengen (TNF 
receptor) play roles in dorsal closure, neuroblast divisions, and the response to fungal 
pathogens (Kauppila et al., 2003; Schneider et al., 2007; Wang et al., 2006). A role for 
TNF signaling in early Drosophila embryogenesis has not been reported to our 
knowledge. 
TRIP was recently reported to be an essential factor in mice (Park et al., 2007). 
TRIP-deficient mice die soon after implantation due to defects in early embryonic 
development. Compared to wild-type littermates, TRIP-/- embryos are smaller in size with 
reduced cell number. TRAF2 does not appear to be required until later in development, 
suggesting that TRIP has TRAF2-independent roles in early embryos (Nguyen et al., 
1999). It will be interesting to see whether mammalian TRIP, by analogy to Drosophila 
NOPO, is required for genomic integrity during embryonic development.   
Our data support a model in which NOPO ubiquitin ligase acts in concert with 
BEN-UEV1A heterodimers to regulate Drosophila syncytial embryogenesis. The yeast 
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two-hybrid interaction and co-localization of NOPO and BEN led us to identify an 
unanticipated role for BEN in early embryogenesis and additional roles for NOPO in 
synapse formation and innate immunity. While the spindle defects of ben-derived 
embryos are strikingly similar to those of nopo, they typically arrest earlier in syncytial 
development, suggesting that another E3 ligase that requires BEN may function in 
parallel with NOPO. Although nopo egg chambers appear normal, we have not ruled out 
a possible requirement for BEN-UEV1A-NOPO complexes during oogenesis; some 
defects in nopo- and ben-derived embryos could be a secondary consequence of previous 
defects during oogenesis. 
K63-linked ubiquitin chains are thought to act as non-proteolytic signals (e.g. 
affecting protein localization and/or interactions), whereas K48-linked ubiquitin chains 
have established roles in targeting proteins for proteasome-mediated degradation (Pickart 
and Fushman, 2004). BEN-UEV1A E2 homologs in budding yeast (Ubc13-Mms2p) 
mediate K63-linked polyubiquitination of PCNA during postreplicative repair (Andersen 
et al., 2005). In mammalian cells, the E2 heterodimer Ubc13-Mms2 mediates DNA 
damage repair, while Ubc13-Uev1A promotes NF-κB activation; both E2 complexes 
regulate these processes by mediating K63 ubiquitin chain assembly on target proteins. 
We propose that BEN-UEV1A-NOPO (E2-E3) complexes mediate assembly of K63-
linked ubiquitin chains on proteins that preserve genomic integrity in early Drosophila 
embryogenesis. 
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CHAPTER III 
 
YEAST TWO-HYBRID SCREEN IDENTIFIES TRIP INTERACTORS 
 
INTRODUCTION 
In order to monitor the integrity of the genome and to prevent the transmission of 
genetic errors to daughter cells during cell division, the cell employs a complex network 
of regulatory proteins that sense DNA damage and either repair it or block cell-cycle 
progression. DNA damage can occur at any stage of the cell cycle, exists in many forms 
and may result from many different sources. Disruption of the DNA damage response 
(DDR) may result in unrepaired DNA damage and uncontrolled proliferation (reviewed 
by Zhou and Elledge, 2000), which may result in pathologies such as cancer can result. 
In animal cells, the DDR, which may result in a permanent cell-cycle arrest or cell 
death, is largely controlled by the tumor suppressor p53. p53, a transcription factor that is 
activated by ATM and ATR, is required to turn on transcription of several target genes 
involved in the prevention of cell-cycle progression and the initiation of apoptosis (Hirao 
et al., 2000). p53 activity is positively regulated by the acetyltransferase p300 and the 
kinases ATR, ATM and Chk2. p53 is also negatively regulated, mostly by the ubiquitin-
proteasome system and the E3 ubiquitin ligase MDM2 (Oliner et al., 1993). A major 
target of p53 transcriptional activity is the Cdk inhibitor p21, which inhibits Cdk/cyclin 
and prevents cell-cycle progression at G1/S (Shivji et al., 1994). If the DDR is prolonged, 
many cells initiate p53-mediated apoptosis. Because p53 is such a critical player in the 
DDR of animal cells, it is not surprising that it is the single most frequently mutated 
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protein in cancer cells (Soussi, 2003). 
MDM2 (murine double minute 2), one of the E3 ubiquitin ligases for p53, is a 
RING domain-containing oncoprotein. Under normal conditions, MDM2 ubiquitylates 
and shuttles p53 out of the nucleus for degradation by the proteasome (Oliner et al., 1993; 
Lee and Gu, 2010; Marine and Lozano, 2010). In the presence of DNA damage or 
cellular stress, the tumor suppressor p19ARF blocks MDM2-mediated p53 ubiquitylation 
and nuclear export by interacting with and relocalizing MDM2 to the nucleolus (Wang et 
al., 2006). MDM2 can no longer ubiquitylate and promote the degradation of p53 once it 
is sequestered to the nucleolus. The nucleolus is the site of ribosomal RNA biosynthesis, 
but other roles for the nucleolus in cell-cycle progression and DNA repair suggest this 
nuclear compartment is multifaceted (Boisvert et al., 2007). MDM2 also has several p53-
independent roles: MDM2 can affect cell-cycle checkpoints, DNA and centrosome 
replication, and DNA-repair pathways independent of p53 (Bouska and Eischen, 2009). 
MDM2 is essential for viability and development, as MDM2 homozygous mutant mice 
are embryonic lethal (Bond et al., 2005). 
LZAP (also named CDK5RAP3 or C53) is a tumor suppressor that plays 
important roles in multiple cell processes, including the DDR and NF-κB signaling 
(Wang et al., 2006; Wang et al., 2007). LZAP is deposited maternally and highly 
conserved from plants to humans. Overexpression of LZAP promotes Cdk1 activity and 
the nuclear accumulation of cyclin B (Jiang et al., 2009). LZAP also interacts with and 
inhibits Chk1, thereby promoting Cdk1 activation and mitotic entry. These and other data 
suggest that LZAP plays a critical role in modulating the G2/M DNA damage checkpoint. 
Recently, the zebrafish homolog of LZAP was shown to be involved in cell cycle 
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progression and embryonic development (Liu et al., 2011). Zebrafish embryos injected 
with a morpholino designed to inhibit LZAP translation exhibit a delay in G2/M and 
arrest during early embryogenesis due to a failure to initiate epiboly. Preliminary studies 
on LZAP homozygous mutant mice are consistent with the findings in zebrafish; LZAP 
null mice die during early embryonic development (Liu et al., 2011). These data suggest 
critical roles for LZAP during cell cycle progression and development. 
Above, I described a Drosophila maternal effect-lethal mutant no poles (nopo) 
(Merkle et al., 2009). Embryos from nopo females undergo mitotic arrest during the rapid 
S-M cycles of syncytial embryogenesis. Checkpoint kinase 2 (Chk2) plays a unique 
checkpoint function in the early Drosophila embryo as it is locally activated in response 
to DNA damage or incomplete replication. Our genetic data indicate that Chk2 is 
activated in nopo mutants, suggesting that NOPO plays a role in preserving genomic 
integrity during early Drosophila embryogenesis. We also showed that syncytial embryos 
lacking NOPO exhibit a significantly shorter interphase 11 as compared to wild type, 
suggesting that nopo mutants may enter mitosis prior to the completion of DNA 
replication, thereby triggering Chk2 activation (Merkle et al., 2009). 
The candidate RING domain-containing E3 ubiquitin ligase, NOPO, is 
homologous to human TRAF-interacting protein (TRIP). Tumor necrosis factor receptor 
(TNFR)-associated factors (TRAFs) are key adaptor molecules in the TNF-signaling 
pathway that regulates cell proliferation, activation, differentiation and apoptosis 
(reviewed by Ha et al., 2009). However, TRIP’s physiological role in TNF signaling is 
unclear (Lee et al., 1997; Regamey al., 2003). Although substrates of mammalian TRIP 
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have not been reported to date, the mouse TRIP homolog is a functional E3 ligase based 
on its in vitro auto-ubiquitylation activity (Besse et al., 2007). 
Protein ubiquitylation plays an important role in many cellular processes, 
including protein processing, cell cycle control, chromatin remodeling, DNA repair, and 
membrane trafficking (Liu and Chen, 2011; Broemer and Meier, 2009; Le Bras et al., 
2011; Acconcia et al., 2009; Hershko, 1997; Al-Hakim et al., 2010; O’Connell and 
Harper, 2007). Ubiquitylation involves the covalent linkage of one or more ubiquitin 
molecules to another protein. The resulting modification may alter its fate in a number of 
ways, including destruction by the 26S proteasome, a change in subcellular location, or a 
change in protein-protein interactions (Glickman and Ciechanover, 2002). E3s serve as 
the specificity factors in the multi-step process of ubiquitylation, as they bind both the E2 
conjugating enzyme (E2) and the substrate to be ubiquitylated.  
To identify potential ubiquitylation substrates of the E3 ligases NOPO and TRIP 
and elucidate the mechanism by which NOPO/TRIP promotes genomic stability, we 
performed a yeast two-hybrid screen for TRIP interactors. We report here the results of 
this screen and the subsequent follow-up on several interesting interactors. In particular, 
we focus in this chapter on the interaction of mammalian TRIP with MDM2 (an E3 
ubiquitin ligase for p53) and the tumor suppressor LZAP. Identification and subsequent 
characterization of the interaction of NOPO/TRIP with members of the Y family of DNA 
polymerases will be the focus of the next chapter (Chapter 4). 
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RESULTS 
 
TRIP interactors identified via yeast two-hybrid screen 
RING-containing E3 ligases often interact directly with their substrates (Deshaies 
and Joazeiro, 2009). To identify potential substrate(s) of NOPO and hTRIP, we 
performed a yeast two-hybrid screen. Human TRIP cDNA was cloned into pGBKT7 
vector (Matchmaker III from Clontech), transformed into yeast, and expression was 
verified by Western blot analysis (data not shown). A HeLa cell cDNA library was used 
to screen for clones that interact with yeast expressing the pGBKT7-hTRIP bait plasmid. 
Sequence analysis of 190 clones revealed the identity of 67 non-redundant hits (Figure 
3.1; Table 3.1). We classified about 77% of these hits as common false positives 
(including mitochondrial, ribosomal and uncharacterized proteins) (Fig. 3.2). We further 
narrowed down the list of hits to pursue by prioritizing those that would help to place 
NOPO/TRIP within a molecular framework, in particular to elucidate the mechanism by 
which NOPO promotes genomic integrity during early embryonic development in 
Drosophila. This shortened list includes proteins involved in cell cycle, DNA damage 
and/or protein ubiquitylation (Table 3.2). 
 
Confirmation of TRIP/NOPO interactors via yeast two-hybrid assays 
To confirm interactions between TRIP and candidate hits from the primary 
screen, we individually retested their interactions with TRIP via yeast two-hybrid assays 
by cloning each full-length cDNA into pGADT7 and transforming the prey plasmids into 
yeast. We found that TSG101, MAGOH and MDM2 reproducibly interact with TRIP in  
67 
 
 
Figure 3.1: Yeast two-hybrid screen for TRIP interactors. Human TRIP cDNA was 
subcloned into pGBKT7 to encode a hybrid TRIP protein containing the DNA-binding 
domain of Gal4. Yeast cells of the AH109 strain were transformed with pGBKT7-hTRIP 
and mated with yeast cells pretransformed with a HeLa cDNA library (Clontech). 
Transformants were selected on minimal media lacking His, Leu and Trp (triple dropout, 
TDO) selection medium. Details of the follow-up for this screen are described in the text. 
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Table 3.1. List of hits from yeast two-hybrid screen using hTRIP as bait and HeLa cDNA library as prey. 
Gene symbol Gene ID Gene name 
# of times isolated 
in screen 
AIP 9049 aryl hydrocarbon receptor interacting protein 1 
AKR1B1 231 
aldo-keto reductase family 1, member B1 (aldose 
reductase) 
2 
ARID2 196528 AT rich interactive domain 2 (ARID, RFX-like) 1 
ATP5A1 498 
ATP synthase, H+ transporting, mitochondrial F1 
complex, alpha subunit 1 
1 
CCT7 10574 chaperonin containing TCP1, subunit 7 (eta) 1 
CD63 967 CD63 antigen 1 
CDK5RAP3 80279 CDK5 regulatory subunit associated protein 3 1 
CNPY3 10695 canopy 3 homolog (zebrafish) 1 
COPS6 10980 
COP9 constitutive photomorphogenic homolog subunit 
6 (Arabidopsis) 
1 
DCTN1 1639 dynactin 1 (p150, glued homolog, Drosophila) 1 
DENND4C 55667 DENN/MADD domain containing 4C 1 
EBP 10682 emopamil binding protein (sterol isomerase) 1 
EEF1A1 1915 eukaryotic translation elongation factor 1 alpha 1 2 
EIF4A1 1973 eukaryotic translation initiation factor 4A, isoform 1 1 
ENO1 2023 enolase 1, (alpha) 2 
ETFA 2108 electron-transfer-flavoprotein, alpha polypeptide 8 
FAM20C 56975 family with sequence similarity 20, member C 1 
FTL 2512 ferritin, light polypeptide 8 
GMPS 8833 guanine monphosphate synthetase 1 
GNB2L1 10399 
guanine nucleotide binding protein (G protein), beta 
polypeptide 2-like 1 
1 
IFRD2 7866 interferon-related developmental regulator 2 2 
JAK3 3718 Janus kinase 3 1 
MAGOH 4116 mago-nashi homolog, proliferation-associated 1 
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(Drosophila) 
MDM2 4193 Mdm2 p53 binding protein homolog (mouse) 1 
MESDC2 23184 mesoderm development candidate 2 3 
NDUFB10 68342 
NADH dehydrogenase (ubiquinone) 1 beta 
subcomplex, 10 
1 
NDUFV1 4723 NADH dehydrogenase (ubiquinone) flavoprotein 1 1 
NINL 22981 ninein-like 1 
PCOLCE 5118 procollagen C-endopeptidase enhancer 1 
PEA15 8682 phosphoprotein enriched in astrocytes 15 1 
PEX12 5193 peroxisomal biogenesis factor 12 1 
POLK 51426 polymerase (DNA directed) kappa 1 
POLR2E 5434 polymerase (RNA) II (DNA directed) polypeptide E 5 
POLR2G 5436 polymerase (RNA) II (DNA directed) polypeptide G 1 
RASSF7 8045 
Ras association (RalGDS/AF-6) domain family (N-
terminal) member 7 
1 
RNASET2 8635 ribonuclease T2 1 
RPL11 6135 ribosomal protein L11 4 
RPL31 6160 ribosomal protein L31 3 
RPS14 6208 ribosomal protein S14 1 
RPS7 6201 ribosomal protein S7 2 
SAMD11 148398 sterile alpha motif domain containing 11 1 
SART1 9092 squamous cell carcinoma antigen recognized by T cells 1 
SAT1 6303 spermidine/spermine N1-acetyltransferase 1 3 
SBF2 81846 SET binding factor 2 1 
SC4MOL 6307 sterol-C4-methyl oxidase-like 1 
SERINC3 10955 serine incorporator 3 1 
SFRS7 6432 splicing factor, arginine/serine-rich 7 1 
SOD2 6648 superoxide dismutase 2, mitochondrial 1 
TAF1 6872 
TAF1 RNA polymerase II, TATA box binding protein 
(TBP)-associated factor 
2 
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TARBP1 6894 TAR (HIV-1) RNA binding protein 1 1 
TBC1D5 9779 TBC1 domain family, member 5 1 
TINAGL1 64129 tubulointerstitial nephritis antigen-like 1 1 
TSG101 7251 tumor susceptibility gene 101 1 
TXNDC9 10190 thioredoxin domain containing 9 1 
UNC84A 23353 unc-84 homolog A (C. elegans) 2 
USP15 9958 ubiquitin specific peptidase 15 1 
VDAC2 7417 voltage-dependent anion channel 2 2 
VIL1 7429 villin 1 1 
VKORC1 79001 vitamin K epoxide reductase complex, subunit 1 1 
WWC3 55841 WWC family member 3 2 
YBX1 4904 Y box binding protein 1 2 
ZBED4 9889 zinc finger, BED-type containing 4 1 
ZDHHC6 64429 zinc finger, DHHC domain containing 6 2 
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Figure 3.2: Gene Ontology (GO) classification of yeast two-hybrid hits. GO 
categories were assigned using PANTHER (www.pantherdb.org). (A) Pie chart of yeast 
two-hybrid hits classified into GO biological process categories. (B) Pie chart of yeast 
two-hybrid hits classified into GO molecular function categories. The percentage of 
genes classified in each category is indicated. Genes may be assigned to multiple 
categories by this program. 
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Table 3.2: Highest priority hits obtained from TRIP yeast two-hybrid screen. 
Gene name:  Known functions: 
TSG101 (tumor 
susceptibility gene 101) 
E2 conjugating enzyme variant 
Drosophila homolog, erupted, involved in JAK-STAT 
signaling 
MDM2 (murine double 
minute 2, homolog) 
E3 ubiquitin ligase for p53 
Sequestered to the nucleolus by pARF in the presence of 
DNA damage 
POLK (DNA polymerase 
kappa) 
Y-family DNA polymerase involved in translesion 
synthesis during S-phase 
CDK5RAP3/LZAP (CDK5 
regulatory subunit associated 
protein 3) 
Role in NF-κB signaling & tumor progression 
Knockdown delays Cdk1 activation & mitotic entry 
MAGOH (mago nashi 
homolog) 
Regulates transcriptional activation of STAT3 
Required for germline stem cell differentiation in 
Drosophila 
USP15 Deubiquitylase (DUB) for IκBα 
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this assay (Fig. 3.3A). We also tested the interaction of NOPO and Drosophila homologs 
of some of the high-priority hits via yeast two-hybrid assays. We found that NOPO 
interacts with MAGO (MAGOH homolog) and CG20391 (LZAP homolog) (Fig. 3.3B). 
These data indicate that TSG101, MAGOH, MDM2 and LZAP are all TRIP/NOPO 
interactors by yeast two-hybrid assay and thereby represent potential substrates of these 
E3 ubiquitin ligases.  
 
Confirmation of MDM2 and LZAP as TRIP interactors in cultured mammalian 
cells 
To determine whether these interactions occur in cultured cells, we coexpressed 
MYC-tagged TRIP with FLAG-tagged human MDM2 or LZAP in HeLa cells. We found 
that FLAG-MDM2 and FLAG-LZAP were both coimmunoprecipitated with MYC-TRIP 
(Fig. 3.4A,B). These interactions were also confirmed in the reverse direction: MYC-
TRIP was present in immunoprecipitates of the FLAG-tagged proteins (Fig 3.4C). 
We previously reported the subcellular localization of eGFP-TRIP (N-terminally 
tagged) transiently expressed in HeLa cells to nuclear puncta during G2 phase (Merkle et 
al., 2009). Another group reported that endogenous TRIP localizes to the nucleolus (Zhou 
and Geahlen, 2009). We confirmed their results by transiently transfecting TRIP-
mCherry (C-terminally tagged) into Hela cells and colocalizing TRIP with a nucleolar 
marker; however, we also observed TRIP-mCherry localized to nuclear puncta in these 
transfected cells (Fig 3.5; data not shown). 
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Figure 3.3: Confirmation of TRIP and NOPO interactors in yeast two-hybrid 
assays. Yeast cells expressing TRIP or NOPO baits fused to the DNA-binding domain of 
Gal4 (BD) and full-length preys fused to the Gal4 activation domain (AD) were spotted 
onto selective media. Physical interactions were tested by spotting diluted cells onto 
triple dropout (TDO) medium (-Trp, -Leu, -His) and scoring growth after 3 days at 30°C. 
SV40 T-antigen (SV40-T) was used as a negative control prey for all bait constructs. (A) 
Full-length human TRIP was used as bait. TRIP interacts with TSG101, MAGOH, and 
MDM2. (B) Full-length NOPO was used as bait. NOPO interacts with MAGO and 
CG30291. 
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Figure 3.4: TRIP interacts with MDM2 and LZAP in cultured mammalian cells. (A-
B) HeLa cells were co-transfected with MYC-tagged TRIP or empty vector and FLAG-
tagged MDM2 (A) or LZAP (B). MYC-TRIP complexes were immunoprecipitated (IP) 
from cell lysates and resolved by SDS-PAGE/immunoblotting. FLAG-MDM2 (A) and 
FLAG-LZAP co-immunoprecipitated with MYC-TRIP. (C) HeLa cells with co-
transfected with FLAG-tagged LZAP, MDM2, or empty vector (EV) and MYC-TRIP. 
FLAG-tagged protein complexes were immunoprecipitated from cell lysates and resolved 
by SDS-PAGE/immunoblotting. MYC-TRIP co-immunoprecipated with FLAG-MDM2 
and FLAG-LZAP. Immunoblotting of whole cell lysates (WCL) used in all IP assays is 
shown. 
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Figure 3.5: MDM2 co-localizes with TRIP in cultured mammalian cells. 
Immunofluorescence microscopy of HeLa cells co-transfected with TRIP-eGFP (green) 
and mCherry-MDM2 (red). DNA is in blue. TRIP-eGFP localizes to nuclear puncta and 
nucleoli mCherry-MDM2 localizes to the nucleus and the nucleolus. The merged image 
shows co-localization of TRIP and MDM2 to nucleoli. Bars, 10 µm. 
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TRIP co-localizes with MDM2 to the nucleus and nucleolus 
Provided the reported endogenous localization of MDM2 to the nucleus and 
nucleolus, we questioned whether TRIP might interact with MDM2 at these subcellular 
sites (Chen and Chen, 2003). We compared the localization patterns of fluorescently 
tagged versions of these proteins in transfected HeLa cells and found that TRIP 
colocalized with MDM2 in transfected HeLa cells (Fig. 3.5). These data support a model 
in which TRIP interacts with MDM2 in the nucleolus. 
 
DISCUSSION 
Although the function of TRIP at the nucleolus is unknown, this nuclear 
compartment has been shown to be a site at which proteins are sequestered and held 
inactive (Boisvert et al., 2007). The nucleolus is the site of ribosome biosynthesis, 
although many other roles have been reported. Our identification of several cDNAs 
encoding ribosomal proteins in our yeast two-hybrid screen may actually be due to 
TRIP’s subcellular localization rather than representing false-positive interactions. 
Interestingly, MDM2 is sequestered to the nucleolus in the presence of DNA damage so 
as to block ubiquitylation and degradation of the tumor suppressor p53. Based on TRIP’s 
localization and interaction with the E3 ubiquitin ligase MDM2, we favor a model in 
which TRIP ubiquitylates and sequesters its substrates to the nucleolus under certain 
cellular conditions (i.e. cell-cycle stage or genotoxic stress). By analogy to the regulation 
of MDM2 by p19ARF, when TRIP’s substrate(s) is needed, we predict its release from the 
nucleolus is triggered. 
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We also identified in our screen proteins associated with cellular metabolism, 
apoptosis and NF-κB signaling. These hits could be associated with TRIP’s role in TNF 
signaling. Although TRIP’s physiological role in TNF signaling is unclear, the TNF-
signaling pathway is linked to cell proliferation, activation, differentiation and apoptosis 
(Lee et al., 1997; Regamey et al., 2003). When TRIP is knocked down in keratinocytes,  
cells exhibit an NF-κB-independent G1/S phase cell-cycle arrest (Almeida et al., 2011). 
There is also evidence that mammalian TRIP is essential during development; 
homozygous mutant mouse embryos die shortly after implantation with proliferation 
defects and excessive cell death (Park et al., 2007). This early embryonic developmental 
arrest occurs prior to when TNF signaling is first required, suggesting that TRIP has 
critical roles outside of its proposed TNF-signaling functions (Gerhart, 1999). This role 
for TRIP may be linked to MDM2 and/or LZAP, as MDM2 and LZAP mutant mice 
similarly die in early embryonic development. It will be interesting to see if any of these 
proposed roles for TRIP in apoptosis and cell proliferation involve its interaction with 
LZAP and/or MDM2. Further investigation is likely to reveal new roles for TRIP in 
TNF-dependent and –independent processes. 
It will also be important to determine if TRIP’s interactions with LZAP and 
MDM2 are that of an E3 ligase and its substrates. Further experiments are necessary in 
order to better understand TRIP’s role in regulating LZAP and MDM2. Because all of 
these proteins have been implicated in cell-cycle progression, genome maintenance, and 
development, uncovering the mechanisms by which these proteins functionally interact 
will be informative. Characterization of the Drosophila LZAP homolog, CG30291, has 
not been reported; similarly, identification of a functional MDM2 homolog in Drosophila 
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has yet to be reported (Sekelsky et al., 2000). We are particularly interested in future 
efforts to investigate the potential roles of NOPO in regulating MDM2 and LZAP 
homologs during early Drosophila embryogenesis. 
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CHAPTER IV 
 
REGULATION OF TRANSLESION DNA POLYMERASES BY THE E3 
UBIQUITIN LIGASES TRIP/NO POLES 
 
INTRODUCTION 
The early embryonic development of organisms such as Drosophila 
melanogaster, Xenopus laevis, Danio rerio and Caenorhabditis elegans are characterized 
by a rapid progression through the cell cycle (O’Farrell et al., 2004; Budirahardja and 
Gönczy, 2009). These rapid cell cycles of early embryogenesis may have evolved as a 
survival strategy due to the exposed environment in which the animals develop. The early 
embryonic cell cycles of Drosophila consist of oscillating rounds of DNA replication and 
mitosis with no intervening gap phases or cytokinesis. Cell-cycle regulators are provided 
maternally and slowly depleted until the mid-blastula transition (MBT).  
Most eukaryotic cells employ highly regulated responses to damaged DNA. In the 
presence of DNA lesions, the PI3-like kinases ATR and ATM and their effector kinases, 
Chk1 and Chk2, are activated, thereby triggering a signaling cascade to respond to and 
repair the damage. The Drosophila syncytial embryo lacks a G2 phase, so it does not 
allow time for canonical cell cycle checkpoints to repair damaged DNA. During early 
embryogenesis in Drosophila, mei-41, the ATR homolog, and grapes (grp), the Chk1 
homolog, are required to slow the late syncytial cell cycles (11-13) in order to introduce a 
G2 phase at cellularization (Sibon et al., 1999; Fogarty et al., 1994; Sibon et al., 1997). 
Embryos from mei-41 or grp mutant females fail to lengthen interphase in the late 
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syncytial cycles and enter mitosis with incompletely replicated DNA, thus highlighting a 
unique role of DNA damage machinery during development. 
Just as the eukaryotic cell possesses many mechanisms to repair damaged DNA, 
cells also possess mechanisms to temporarily tolerate DNA damage until the DNA repair 
machinery can effectively repair the damage. Translesion synthesis (TLS), which 
promotes the completion of DNA replication instead of repairing damaged DNA, is one 
of the processes used by the cell to bypass damage during S phase. This process is 
initiated by the monoubiquitylation of PCNA, which subsequently triggers the 
recruitment of specialized DNA polymerases to the replication fork (Friedberg et al., 
2002). These specialized polymerases are Polζ (also referred to as Rev3), a member of 
the B family of DNA polymerases, and members of the Y family of DNA polymerases; 
the latter group consists of Rev1, Polι (POLI), Polη (POLH), and Polκ (POLK) 
(reviewed by Shaheen et al., 2010; Lehmann, 2006).  
The Y family of DNA polymerases is conserved from bacteria to humans. 
Ultraviolet light (UV) is a major trigger to recruit these polymerases to stalled replication 
forks (Waters et al., 2009; Jarosz et al., 2007; Lehmann, 2006). Mutation of one of the 
human Y-family polymerases, POLH, results in a variant form of Xeroderma 
Pigmentosum (XP-V), a disease characterized by UV sensitivity and a high susceptibility 
to skin cancers (Masutani et al., 1999; Kannouche and Stary, 2003; Kannouche et al., 
2001). polh-/- null mice also exhibit high mutation frequencies and UV-induced epithelial 
tumors (Busuttil et al., 2008; Ohkumo et al., 2006).  
Drosophila has three members of the Y family of DNA polymerases: DNApol-
eta, DNApol-iota and Rev1. Drosophila DNApol-eta and DNApol-iota are functional 
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translesion polymerases in vitro (Ishikawa et al., 2001), but there are no reported mutant 
alleles for the genes encoding these polymerases in flies. Knockdown of polh-1, the C. 
elegans DNApol-eta homolog, in the germ line results in increased sensitivity of early 
embryos to UV radiation (Ohkumo et al., 2006). Recent studies suggest that POLH-1 
may play a key role during early C. elegans embryogenesis to keep the rapid cycles on 
schedule (Holway et al., 2006; Kim and Michael, 2008). Because the Y polymerases are 
conserved in eukaryotes and expressed during early development, it seems likely that Y-
family polymerases play similar roles in cell-cycle progression during the development of 
other organisms. 
We previously described a Drosophila maternal effect-lethal mutant that we 
named “no poles” (nopo) (Merkle et al., 2009). Embryos from nopo females undergo 
mitotic arrest during the rapid S-M cycles of syncytial embryogenesis. Checkpoint kinase 
2 (Chk2) plays a unique checkpoint function in the Drosophila early embryo as it is 
locally activated in response to DNA damage or incomplete replication. We showed that 
Chk2 is activated in nopo mutants, suggesting that NOPO plays a role in preserving 
genomic integrity during early embryogenesis of Drosophila. We also showed that 
syncytial embryos lacking NOPO exhibit a significantly shorter interphase 11 as 
compared to wild type, suggesting that nopo mutants may enter mitosis prior to the 
completion of DNA replication, thereby triggering Chk2 activation. 
nopo, which encodes a candidate RING domain-containing E3 ubiquitin ligase, is 
the Drosophila homolog of a human gene encoding TRAF-interacting protein (TRIP). 
Tumor necrosis factor receptor (TNFR)-associated factors (TRAFs) are key adaptor 
molecules in the TNF-signaling pathway that result in cell proliferation, activation, 
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differentiation, and apoptosis (reviewed by Ha et al., 2009); however TRIP’s 
physiological role in TNF signaling is unclear (Lee et al., 1997; Regamey et al., 2003). 
Although substrates of mammalian TRIP have not been reported to date, the mouse TRIP 
homolog is a functional E3 ligase in vitro (Besse et al., 2007). 
Ubiquitylation is a posttranslational modification that plays an important role in 
many cellular processes, including protein processing, cell cycle control, chromatin 
remodeling, DNA repair, and membrane trafficking (Liu and Chen, 2011; Broemer and 
Meier, 2009; Le Bras et al., 2011; Acconcia et al., 2009; Hershko, 1997; Al-Hakim et al., 
2010; O’Connell and Harper, 2007). Modification of proteins by ubiquitylation is a multi-
step process that involves a ubiquitin activating enzyme (E1), ubiquitin conjugating 
enzymes (E2s or Ubcs), ubiquitin ligases (E3s), and ubiquitin (Ub) (reviewed by Fang 
and Weissman, 2004; Weissman, 2001; Wilkinson, 2000). Ubiquitylation involves the 
linkage of one or more ubiquitin molecules to another protein; the resulting modification 
may alter its fate in a number of ways, including the following: targeting it for destruction 
by the 26S proteasome, changing its subcellular location, or changing its protein-protein 
interactions (Glickman and Ciechanover, 2002).  
To identify potential ubiquitylation substrates of the E3 ligases NOPO and TRIP 
and to elucidate the mechanism by which NOPO/TRIP promotes genomic stability, we 
performed a yeast two-hybrid screen using human TRIP. We report here the interaction 
of Drosophila NOPO and mammalian TRIP with members of the Y family of DNA 
polymerases. We show that the E3 ligases NOPO and TRIP enhance the ubiquitylation of 
the Y polymerase proteins, suggesting that NOPO plays an important role in regulating 
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the Y-family polymerases during the rapid syncytial cell cycles of Drosophila 
embryogenesis. 
 
RESULTS 
 
Drosophila NOPO and mammalian TRIP are functional homologs 
We previously described a Drosophila maternal effect-lethal mutant that we 
named “no poles” (“nopo”) (Merkle et al., 2009). nopo, which encodes a candidate RING 
domain-containing E3 ubiquitin ligase, is the Drosophila homolog of a human gene 
encoding TRAF-interacting protein (hTRIP). To test functional conservation of the 
human and Drosophila homologs, we investigated whether transgenic expression of 
human hTRIP could rescue fly nopo mutants. Embryos derived from nopo females 
undergo mitotic arrest with barrel-shaped, acentrosomal spindles during the rapid S-M 
cycles of syncytial embryogenesis (Fig. 4.1C,D). We first tested whether these defects of 
nopo mutants could be rescued by expressing nopo cDNA under the control of the 
endogenous nopo promoter (nopo cDNA rescue, Fig. 4.1A). We found that this transgene 
restored fertility to nopo females: whereas embryos from control nopo females never 
hatched into larvae, embryos produced by nopo females carrying the nopo cDNA rescue 
transgene exhibited a 67% hatch rate compared to 82% in wild type (Fig. 4.1B). To test 
where NOPO and hTRIP are functionally conserved, we similarly expressed human 
hTRIP under the control of the endogenous nopo promoter (hTRIP cDNA rescue) (Fig. 
4.1A). Fertility was restored in nopo mutant females carrying the hTRIP cDNA rescue 
transgene, resulting in a 59% hatch rate (Fig. 4.1B). Mitotic spindles were also restored to  
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Figure 4.1: Human TRIP is the functional homolog of Drosophila NOPO. (A) nopo 
genomic region (top). Coding regions are represented by black boxes, 5’- and 3’-UTRs 
by white boxes, spliced regions by lines. Arrows indicate transcription direction. 
Transgenic rescue constructs (bottom). Rescue constructs contained genomic sequences 
flanking nopo (lines), 5’- and 3’-UTRs of nopo (white boxes), and coding regions of 
nopo or hTRIP cDNA (dashed lines). (B) The sterility of nopoExc mutant females is 
almost completely rescued by transgenic expression of either nopo or hTRIP cDNA 
(constructs shown in A). (C-F) Representative mitotic spindles in syncytial embryos from 
females of the following genotypes: wild-type (C), nopo (D), or nopo with transgenic 
expression of NOPO (E) or hTRIP (F). Microtubules are in green and DNA in red. Bar, 
10 µm. 
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a wild-type morphology in embryos from nopo females expressing either the nopo or 
hTRIP cDNA rescue transgenes (Fig. 4.1E,F). Thus, Drosophila NOPO and human TRIP 
are functionally conserved. 
 
TRIP interacts with Y-family DNA polymerases via yeast two-hybrid assays 
RING-containing E3 ligases often interact directly with their substrates (Deshaies 
and Joazeiro, 2009). To further understand NOPO’s role in maintaining genomic integrity 
during early embryonic development in Drosophila, we sought to identify potential 
substrate(s) of NOPO by performing a yeast two-hybrid screen. Due to a lack of 
commercially available, high-quality cDNA libraries prepared from Drosophila early 
embryos, we chose to carry out our yeast-two hybrid screen using the human homolog of 
NOPO, TRIP, as the bait and a HeLa cell cDNA library as the prey. Human TRIP cDNA 
was cloned into pGBKT7 vector (Matchmaker III from Clontech) and transformed into 
yeast, and expression of TRIP was verified by Western blot analysis (data not shown). 
Using yeast expressing the pGBKT7-hTRIP plasmid as the bait strain, we screened yeast 
pretransformed with a HeLa cell cDNA library for two-hybrid interactions (see Methods 
chapter for details). Sequence analysis revealed that one of the first clones to appear on 
selective media encoded human POLK, a member of the Y family of DNA polymerases. 
To determine if TRIP interacts with other members of the Y family of DNA 
polymerases, which includes POLH, POLI, POLH and REV1, we individually tested 
each of these polymerases for interaction with TRIP via yeast two-hybrid assay. We 
cloned cDNAs encoding full-length and truncated versions of these polymerases into 
pGADT7 and transformed the prey plasmids into yeast. We found that all four family 
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members interact with TRIP (Fig. 4.2A-E). While TRIP exclusively interacts with the C-
terminal half of POLH and POLK, TRIP interacts with both N- and C-terminal halves of 
POLI (Fig. 4.2A-C). These data are consistent with the many known protein-protein 
interaction domains located within the C-terminal region of the Y polymerases (Waters et 
al., 2009).  
We also investigated the region of TRIP that is responsible for its interaction with 
the Y polymerases by generating truncated forms of TRIP bait that were transformed in 
yeast cells. When testing the capacity of the full-length Y polymerase prey proteins to 
interact with these truncated TRIP forms, we found that all four Y polymerases interact 
strongly with the N-terminal half of TRIP and only weakly with the C-terminal half of 
TRIP (Fig. 4.2D,E). These data suggest that TRIP binds the Y polymerases near its RING 
domain (Merkle et al., 2009).  
 
NOPO interacts with Y-family DNA polymerases via yeast two-hybrid assays 
The Y polymerases conserved in Drosophila are DNA-pol-eta, DNApol-iota and 
dREV1 (Fig. 4.6A). To determine if NOPO similarly interacts with the Drosophila Y 
polymerases, we generated yeast expressing pGBKT7-NOPO bait plasmid as well as 
yeast expressing cDNAs encoding full-length or truncated versions of Drosophila Y 
polymerases in the pGADT7 prey plasmid. We found that NOPO interacts with all 
Drosophila Y-family polymerase homologs (Fig 4.2F-I). To map the protein region 
responsible for the Y polymerase-NOPO interaction, we generated truncated forms of 
DNApol-eta and DNApol-iota and tested the capacity of these prey constructs to interact 
with full-length NOPO. We found that the C-terminal halves of DNApol-eta and  
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Figure 4.2: TRIP and NOPO interact with Y-family DNA polymerases in yeast two-
hybrid assays. (A-I) Yeast cells expressing various baits fused to the DNA-binding 
domain of Gal4 (BD, “bait”) and full-length or truncations of members of the indicated Y 
family of DNA polymerases fused to the Gal4 activation activation domain (AD, “prey”) 
were spotted onto selective media. Physical interactions were tested by spotting serially 
diluted cells onto triple dropout (TDO) medium (-Trp, -Leu, -His) and scoring growth 
after 3 days at 30°C. Side by side plating on double dropout (DDO) media (-Trp, -Leu) 
was performed as a control. SV40 T-antigen (SV40-T) was used as a negative control 
prey for all bait constructs. (A-C) Full-length human TRIP was used as bait. TRIP 
interacts with full-length and/or the C-terminal ends of human Y-family DNA 
polymerases POLH (A), POLI (B), and POLK (C). (D,E) Truncations of TRIP were used 
as bait. (D) POLH, POLI, POLK, and REV1 interact with the N-terminal end of TRIP. 
(E) POLI and REV1 also interact with the C-terminal end of TRIP. (F,G) Full-length 
NOPO was used as bait. NOPO interacts with full-length and the C-terminal ends of 
DNApol-eta (F) and DNApol-iota (G). (H,I) Truncations of NOPO were used as bait. (H) 
DNApol-iota and dREV1 interact with the N-terminal end of NOPO. (I) DNApol-eta, 
DNApol-iota, and dREV1 interact with the C-terminal end of NOPO. 
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DNApol-iota are sufficient for interaction with NOPO (Fig. 4.2F,G). These data are 
consistent with our observations that the human Y polymerase proteins similarly interact 
with TRIP via their C-termini (Fig. 4.2A-C). Furthermore, these data fit well with the 
many protein-protein interaction domains previously identified within the C-terminal end 
of the Drosophila Y polymerase proteins (Waters et al., 2009).  
To define the region of NOPO that interacts with the Drosophila Y polymerases, 
we transformed yeast cells with truncated forms of NOPO bait and tested their capacity to 
interact with full-length Y polymerase prey proteins. We found that DNApol-eta interacts 
exclusively with the C-terminal half of NOPO, whereas DNApol-iota and dREV1 interact 
with both N- and C-terminal halves of NOPO (Fig. 4.2H,I). 
 
TRIP/NOPO E3 ligases interact with Y-family polymerases in cultured cells 
To determine whether these interactions also occur in cultured cells, we co-
expressed MYC-tagged human TRIP and epitope-tagged human Y polymerases in HeLa 
cells. We found that POLH, POLI and POLK could each be co-immunoprecipitated with 
TRIP (Fig. 4.3A-C). Similar results were obtained by immunoprecipitating each of the Y 
polymerases and immunoblotting for TRIP (data not shown). We similarly investigated 
the interaction of Drosophila Y polymerases with NOPO in cultured Drosophila S2 cells. 
We co-expressed MYC-tagged NOPO and HA-tagged Drosophila Y polymerases in S2 
cells and found that DNApol-eta and DNApol-iota co-immunoprecipitated with NOPO 
(Fig. 4.3D,E). These data indicate that human and Drosophila Y polymerases can interact 
with TRIP and NOPO, respectively, in cultured cells. Interestingly, we often observe a 
faint slower migrating band of the Y polymerases on immunoblots of cell lysates. These  
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Figure 4.3: TRIP and NOPO interact with Y-family DNA polymerases in cultured 
cells. (A-C) HeLa cells were co-transfected with expression constructs encoding MYC-
tagged TRIP or empty vector plus tagged versions of human Y-family polymerases as 
indicated. MYC-TRIP complexes were immunoprecipitated (IP) from cell lysates and 
resolved by SDS-PAGE/immunoblotting. The Y-family polymerases FLAG-POLH (A), 
FLAG-POLI (B), and HA-POLK (C) co-immunoprecipitated with MYC-TRIP. (D-E) 
Drosophila S2 cells were co-transfected with MYC-tagged NOPO or empty vector plus 
the indicated Drosophila Y-family polymerases. NOPO-MYC complexes were 
immunoprecipitated from cell lysates and resolved by SDS-PAGE/immunoblotting. HA-
DNApol-eta (D) and HA-DNApol-iota (E) co-immunoprecipitated with NOPO-MYC. 
Immunoblotting of whole cell lysates (WCL) used in all IP assays is shown. 
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bands may represent monoubiquitylated forms of the Y polymerases, as reported 
previously (Bienko et al., 2010). 
 
TRIP/NOPO E3 ligases enhance the ubiquitylation of Y-family polymerases in 
cultured cells 
To determine whether the interactions between TRIP/NOPO and the Y 
polymerases is that of E3 ligases and their substrates, we performed ubiquitylation assays 
in cultured cells. To do this, we first tested whether HA-tagged Y polymerases POLH, 
POLI and POLK would become covalently linked to polyhistidine-tagged ubiquitin 
(His6-Ub) in transiently transfected HeLa cells in the presence of MYC-tagged TRIP. As 
a control, we compared ubiquitylation of the HA-tagged Y polymerases in the absence of 
MYC-TRIP. As expected, HA-POLH and HA-POLK are monoubiquitylated in the 
absence of MYC-TRIP (Fig. 4.4A,B). These data confirm previous studies suggesting 
that the mammalian Y polymerases are monoubiquitylated (Bienko et al., 2010). In the 
presence of MYC-TRIP, ubiquitylation of HA-POLH and HA-POLK is enhanced, as 
indicated by the upward smearing on immunoblots of HA-labeled protein in cells co-
expressing His6-Ub, HA-tagged Y polymerase, and MYC-TRIP. The monoubiquitylation 
band and the ubiquitin smear were only observed in the presence of His6-Ub, consistent 
with covalent linkages of His-Ub to the Y polymerases. Unlike POLH and POLK, 
epitope-tagged POLI did not show a significant enhancement of its ubiquitylation in the 
presence of MYC-TRIP in this assay (data not shown). These data show that TRIP can 
promote polyubiquitylation of the Y polymerases POLH and POLK in cultured 
mammalian cells. 
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Figure 4.4: TRIP and NOPO enhance the ubiquitylation of Y-family polymerases. 
(A,B) HeLa cells were co-transfected with expression constructs encoding MYC-TRIP, 
HA-tagged versions of human Y-family DNA polymerases, and polyhistidine-tagged Ub 
(His6-Ub) as indicated. After denaturing cell lysis, nickel affinity chromatography was 
used to recover ubiquitylated proteins, which were resolved by SDS–
PAGE/immunoblotting. MYC-hTRIP enhanced the ubiquitylation of HA-POLH (A) and 
HA-POLK (B). (C,D) Drosophila S2 cells were co-transfected with expression constructs 
encoding NOPO-MYC, HA-tagged versions of Drosophila Y-family DNA polymerases, 
and His6-Ub as indicated. Analysis of ubiquitylated proteins was performed as in (A,B). 
NOPO-MYC enhanced the ubiquitylation of HA-DNApol-eta (C) and HA-DNApol-iota 
(D). Immunoblotting of whole cell lysates (WCL) used in all ubiquitylation assays is 
shown. Intervening lanes were removed in panel D. 
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We similarly investigated the ubiquitylation of Drosophila Y polymerases by 
NOPO in cultured Drosophila S2 cells using a construct we generated to induce the 
expression of His6-Ub. As in mammalian cells, we compared the ubiquitylation of HA-
tagged DNApol-eta and DNApol-iota in the presence or absence of MYC-NOPO (Fig. 
4.4C,D). HA-DNApol-eta and HA-DNApol-iota appear to be monoubiquitylated when 
MYC-NOPO is not co-expressed, suggesting that Drosophila Y polymerases normally 
undergo this modification. Although this modification has been shown in budding yeast, 
C. elegans and mammalian cells, ubiquitylation of the Drosophila Y polymerases has not 
been previously reported (Skoneczna et al., 2007; Kim and Michael, 2008; Jung et al., 
2010; Bienko et al., 2010). We observed similar results as we did for the human 
homologs in the presence of the E3 ligase. With co-expression of MYC-NOPO, 
ubiquitylation of HA-DNApol-eta and HA-DNApol-iota is enhanced, as indicated by the 
upward smearing of HA-labeled protein on immunoblots. Again, the monoubiquitylation 
band and the ubiquitin smear were only observed in the presence of His6-Ub. These data 
show that NOPO can polyubiquitylate the Y polymerases DNApol-eta and DNApol-iota 
in Drosophila cultured cells. 
 
POLH co-localizes with TRIP in cultured human cells 
We previously reported that N-terminally tagged eGFP-TRIP localizes to nuclear 
puncta during G2 phase in transiently transfected HeLa cells (Merkle et al., 2009). 
Another group reported that endogenous TRIP localizes to the nucleolus in MCF7(BD) 
breast epithelial cells (Zhou and Geahlen, 2009). We confirmed their results by 
transiently transfecting C-terminally tagged TRIP-mCherry in HeLa cells and co-
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localizing TRIP with a nucleolar marker; however, we also observe TRIP-mCherry 
localized to nuclear puncta in transfected human cells (data not shown). 
To obtain further evidence that TRIP and the Y-family polymerases interact, we 
compared the localization patterns of fluorescently tagged versions of these proteins in 
transfected HeLa cells. When transfected alone in the absence of UV, eGFP-POLH 
localizes to the nucleus and seldomly to nuclear puncta (Fig. 4.5A). In a low percentage 
of cells, a small pool of eGFP-POLH was detected in the nucleolus; in the majority of 
cells, however, eGFP-POLH is nuclear and does not localize to the nucleolus, as shown 
immuostaining with the nucleolar marker anti-Fibrillarin (Fig. 4.5A). After treatment 
with UV, eGFP-POLH localizes to nuclear puncta, which indicates its recruitment to 
stalled replication forks during translesion synthesis (Kannouche et al., 2003; Kannouche 
and Lehmann, 2006). When eGFP-POLH and TRIP-mCherry were co-transfected in 
untreated cells, however, eGFP-POLH localized to the nucleolus of cells positive for 
TRIP-mCherry nuclear puncta (Fig. 4.5B). After treatment with UV, eGFP-POLH was 
localized both to nuclear puncta and co-localized with TRIP-mCherry to the nucleolus. 
These data suggest that TRIP can recruit Y-family polymerases to the nucleolus and 
provide further evidence for in vivo interactions between these proteins. 
 
Drosophila Y-family polymerases are expressed during early embryogenesis 
We were interested in the potential role of Y-family polymerases as NOPO 
interactors/substrates during early embryogenesis of Drosophila and whether their 
regulation is a key mechanism by which NOPO promotes cell-cycle progression and 
preservation of genomic integrity. The Y polymerases conserved in Drosophila are  
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Figure 4.5: Localization of Y-family polymerases is altered by co-expression with 
TRIP in cultured mammalian cells. Immunofluorescent micrograms of transfected 
HeLa cells. DNA is in blue. (A) eGFP-POLH (green) is diffusely nuclear in untreated 
cells and localizes to small nuclear puncta after UV treatment (20 J/m2). With or without 
UV treatment, eGFP-POLH generally does not co-localize with the nucleolar marker 
anti-Fibrillarin (red). (B) Co-transfection of eGFP-POLH (green) with TRIP-mCherry 
(red) promotes its localization to the nucleolus both in untreated and UV-treated cells 
(merge). Bars, 10 µm. 
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DNA-pol-eta, DNApol-iota and dREV1; a POLK homolog does not appear to be present 
in Drosophila (Fig. 4.6A). To determine if these polymerases are expressed in early 
Drosophila embryogenesis, we performed reverse transcriptase (RT-) PCR on mRNA 
extracted from 0-2 hour Drosophila embryos. We found that all of the Y polymerase 
genes are co-expressed with nopo during syncytial embryogenesis (Fig. 4.6B). These 
results suggest that, as in C. elegans, the Drosophila Y polymerases may have a unique 
role during the maternally-controlled S-M cell cycles of early embryogenesis. 
 
DNApol-eta females have reduced fertility and produce embryos with nopo-like 
defects 
Mutant alleles have not been reported for any of the Drosophila Y-family 
polymerases. We therefore generated a null allele of DNApol-eta (Exc176) via imprecise 
excision of P-element EY07711 inserted in the 5’-UTR of the DNApol-eta gene region 
(Fig. 4.6C; see Chapter 5 for methods). Homozygous DNApol-etaExc176 adults are viable, 
although they appear to have decreased longevity compared to wild type (data not 
shown). DNApol-etaExc176 adult males display wild-type fertility, but homozygous and 
hemizygous mutant females have decreased fertility (~50% of wild type; Fig. 4.6D). This 
reduction in fertility is partially rescued by a transgene expressing HA-tagged DNApol-
eta. Immunostaining of DNApol-etaExc176-derived embryos revealed that they arrest early 
in syncytial development with mitotic spindle defects strikingly reminiscent of those 
observed in embryos from nopo females (Fig. 4.6E,F). Embryos of DNApol-etaExc176 
homozygotes are often (41%) acentrosomal, barrel-shaped, variable in width, and have  
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Figure 4.6: DNApol-eta mutants phenocopy nopo mutants. (A) Conservation of Y-
family polymerases in Homo sapiens and Drosophila melanogaster. (B) nopo and the 
Drosophila Y polymerases DNApol-eta, DNApol-iota, and dRev1 are expressed in 0-2 
hour Drosophila embryos. Reverse transcriptase-polymerase chain reaction (RT-PCR) 
was performed on mRNA derived from syncytial embryos followed by agarose gel 
electrophoresis. Reactions lacking reverse transcriptase (-RT) are shown as controls. (C) 
DNApol-eta gene structure. Coding regions are represented by black boxes, 5’- and 3’-
UTRs by white boxes, and spliced regions by lines. Arrow indicates transcription 
direction. Imprecise excision of P-element EY07711 (indicated by triangle) generated 
DNApol-etaExc176 (gap represents deleted region). (D) Fertility (determined by hatch rates) 
of DNApol-etaExc176 and DNApol-etaExc176/Df(3R)BSC223 females compared to wild type. 
The decreased fertility of DNApol-etaExc176 females is partially rescued by a transgene 
expressing HA-tagged DNApol-eta cDNA. (E) Representative mitotic spindles in 
embryos from wild-type, nopo, or DNApol-etaExc176 females. Staining of nopo-derived and 
DNApol-etaExc176-derived embryos reveals shortened, barrel-shaped spindles with 
detached centrosomes that differ from wild type. Microtubules are in green and DNA in 
red. Bars, 10 µm. (F) Quantification of nopo-like barrel-shaped spindles with detached 
centrosomes in nopo-derived and DNApol-etaExc176-derived embryos. 
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 misaligned chromosomes; similar phenotypes were observed in embryos of DNApol-
etaExc176 hemizygotes (25%) (Fig. 4.6E,F).  
 
DNApol-eta localizes to interphase nuclei in early embryos of Drosophila 
To further investigate the function of DNApol-eta in the early embryo, we 
visualized HA-tagged DNApol-eta protein in transgenic flies during the early syncytial 
divisions and found it to be exclusively localized to interphase nuclei (Fig. 4.7A). This 
localization is consistent with its reported nuclear localization in cultured cells (as in Fig. 
4.5A; Kannouche et al., 2003; Kannouche and Lehmann, 2006).  
 
DNApol-eta interacts with NOPO in early embryos of Drosophila  
Since DNApol-eta mRNA is present in the early embryo, we tested whether 
DNApol-eta protein physically interacts with NOPO during this stage of Drosophila 
development. We expressed HA-DNApol-eta in the female germ line of wild-type and 
nopo null females (as negative control) followed by immunoprecipitation of endogenous 
NOPO. We found that DNApol-eta co-immunoprecipitated with NOPO from wild-type 
embryos (Fig. 4.7B). Interestingly, we typically observe a faint, slower migrating band of 
HA-DNApol-eta on immunoblots of early embryonic lysates. This upward-shifted band 
may represent a monoubiquitylated form of HA-DNApol-eta, as observed in lysates of 
cultured mammalian and Drosophila cells (as in Figs. 4.3,4.4). Taken together, the yeast 
two-hybrid interactions, co-immunoprecipitation, and similar mutant phenotypes that we 
observe suggest that NOPO and DNApol-eta function in a common pathway to preserve 
genomic integrity during early embryonic development in Drosophila. 
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Figure 4.7: DNApol-eta interacts with NOPO and is ubiquitylated in the early 
Drosophila embryo. (A) HA-DNApol-eta is a nuclear protein in the early Drosophila 
embryo. Expression of HA-tagged DNApol-eta was driven by nanos-Gal4 in the female 
germline and syncytial embryos from these females were fixed and immunostained for 
the HA-epitope tag (green) and DNA (red). HA-DNApol-eta is exclusively localized to 
interphase nuclei. Bars, 20 µm. (B) HA-DNApol-eta coimmunoprecipitates with NOPO 
in the early Drosophila embryo. Immunoprecipitation (IP) of endogenous NOPO from 
syncytial embryos derived from wild type or nopo females expressing HA-DNApol-eta 
driven by nanos-Gal4 in the female germline. IP was performed on embryo lysates to 
recover proteins that interact with NOPO, which were resolved by SDS-PAGE and 
immunoblotting. (C) DNApol-eta is ubiquitylated in the early Drosophila embryo. 
Embryos expressing HA-DNApol-eta, in the presence or absence of His7-ubiquitin, was 
driven by nanos-Gal4 in the female germ line of wild type females. Syncytial embryos 
derived from females expressing nanos>His7-ubiquitin, HA-DNApol-eta or nanos>HA-
DNApol-eta were lysed under denaturing conditions and nickel affinity chromatography 
was used to recover ubiquitylated proteins, which were resolved by SDS–PAGE and 
visualized by immunoblotting. 
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DNApol-eta is ubiquitylated in early embryos of Drosophila  
To determine whether the interaction between Drosophila NOPO and DNApol-
eta is that of an E3 ligase and its substrate, we performed an in vivo ubiquitylation assay 
using early embryos. To do this, we first tested whether HA-DNApol-eta could become 
covalently linked to polyhistidine-tagged ubiquitin (His7-Ub) in syncytial embryos with 
transgenic expression of HA-DNApol-eta and His7-Ub (Fig. 4.7C). Using a protocol 
similar to the one we used for HeLa cells, we found that HA-DNApol-eta can be 
polyubiquitylated in early embryos.  
 
DISCUSSION 
Our yeast two-hybrid screen identified members of the Y family of DNA 
polymerases as TRIP interactors. Subsequent work in cultured mammalian cells showed 
that TRIP interacts with and enhances the ubiquitylation of Y polymerases. We also 
found that the Drosophila Y polymerases are NOPO interactors. Because there were no 
reported mutant alleles for the Y polymerases in Drosophila, we generated a null 
mutation in DNApol-eta and observed decreased hatch rates and nopo-like spindle defects 
in embryos from DNApol-eta females. Together, these data suggest that Drosophila 
DNApol-eta has a unique role during early embryogenesis to promote cell-cycle 
progression and that NOPO regulates its activity. We propose a model in which the 
RING-containing E3 ubiquitin ligases NOPO/TRIP interact with and ubiquitylate Y 
polymerases in cultured cells and during syncytial embryogenesis of Drosophila to 
promote genomic integrity, cell-cycle progression, and continuation of development. Our 
previous studies showed that mutation of nopo results in truncation of S-phase and/or 
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spontaneous DNA damage (Merkle et al., 2009). Subsequent mitotic entry results in 
activation of Chk2, which leads to changes in spindle morphology, mitotic arrest, and 
failure of nopo-derived embryos to develop to cellularization. These data led us to 
propose a model in which NOPO regulates timing of S-M transitions in syncytial 
embryos to ensure that S-phase is of sufficient length to allow completion of DNA 
replication prior to mitotic entry.  
In C. elegans, knockdown of the DNApol-eta homolog, polh-1, in the germ line 
results in increased sensitivity of early embryos to UV radiation (Ohkumo et al., 2006). 
This suggests that POLH-1, and perhaps TLS, play important roles in maintaining the 
genome during early embryogenesis. POLH-1 has been further proposed to prevent 
stalling of replication forks during the early embryonic cell cycles by quickly responding 
to and bypassing lesions (Holway et al., 2006; Kim and Michael, 2008). The authors 
proposed that POLH-1 takes the place of replicative polymerases during S-phase (via a 
polymerase-switching event), thereby keeping the rapid early embryonic cell cycles 
progressing on schedule. POLH-1 is regulated by sumoylation and ubiquitylation (Kim 
and Michael, 2008), suggesting that POLH-1 is protected from degradation by 
sumoylation, and ubiquitylation of POLH-1 presumably occurs once POLH-1 has 
successfully bypassed the lesion to prevent the polymerases from binding the chromatin. 
Although ubiquitylation or ubiquitin-mediated proteolysis of POLH-1 by the E3 ligase 
CRL4-Cdt2 has not specifically been shown, POLH-1 is stabilized when cdt-2 is knocked 
down in the embryo. These data suggest a unique role for the Y-family polymerases 
during early embryonic cell cycles. The regulation of POLH-1 during C. elegans 
embryogenesis is important to keep the rapid cycles on schedule, as well as to keep them 
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away from the chromatin when they are not needed. These data support a highly 
regulated polymerase-switching model of the replicative and Y-family polymerases 
during S-phase of developing embryos. Given that the Y polymerases are conserved in 
eukaryotes and expressed during early development, it seems likely that Y-family 
polymerases play roles in cell-cycle progression at this developmental stage in other 
organisms. 
From studies in budding and fission yeast and mammalian cells, UV has been 
shown to be a major trigger to recruit Y-family polymerases to monoubiquitylated PCNA 
at sites of stalled replication forks (Watanabe et al., 2004; Lehmann, 2005). In 
unchallenged cells, mammalian Y-family polymerases are localized throughout the 
nucleus. In the presence of UV, however, the polymerases are recruited to stalled 
replication forks and appear as foci on the chromatin during S-phase. We show that when 
TRIP and POLH are co-expressed in cultured mammalian cells, they co-localize to the 
nucleolus, both in the absence and presence of UV. This suggests that TRIP may play a 
role in the recruitment of POLH to the nucleolus. The function of TRIP at the nucleolus 
is unknown; however, the recruitment of POLH away from nuclear foci in the presence 
of UV when TRIP is co-expressed is particularly striking. We propose that NOPO/TRIP-
dependent ubiquitylation of the Y-family polymerases results in their sequestration to the 
nucleolus, thereby preventing the polymerases from being recruited to monoubiquitylated 
PCNA on the chromatin. We favor a model in which, in the absence of DNA damage, 
TRIP sequesters Y-family polymerases to the nucleolus so they cannot associate with the 
chromatin and interfere with the function of canonical DNA polymerases. When a lesion 
is detected, however, release of the Y-family polymerases from the nucleolus is triggered 
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to allow their interaction with monoubiquitylated PCNA on the chromatin and bypass of 
the DNA lesion. 
TRAFs are key adaptor molecules in the TNF-signaling pathway that result in cell 
proliferation, activation, differentiation and apoptosis; however, TRIP’s physiological 
role in TNF signaling is unclear (Lee et al., 1997; Regamey et al., 2003). Little has been 
reported about TRIP regulation, but a recent study showed that the tumor suppressor Syk 
phosphorylates TRIP in the presence of TNF and that overexpression of TRIP sensitizes 
cells to TNF-induced apoptosis (Zhou and Geahlen, 2009). Furthermore, when TRIP is 
knocked down in keratinocytes, cells exhibit an NF-κB-independent G1/S phase cell-
cycle arrest (Almeida et al., 2011). It will be interesting to see if any of these proposed 
roles for TRIP in apoptosis and cell proliferation involve its regulation of Y polymerases. 
There is also evidence that mammalian TRIP is critical during development. 
Homozygous mutant TRIP mouse embryos undergo an early arrest with proliferation 
defects and excessive cell death (Park et al., 2007). TRIP also has a reported role in 
TNF/NF-κB-dependent sexual dimorphism in developing neurons (Krishnan et al., 2009). 
These data show an upregulation of TRIP in the developing male anteroventral 
periventricular (AVPV) nucleus. The size difference in male versus female AVPV nuclei 
results from apoptosis in developing male neurons. Further investigation is likely to 
reveal new developmental roles for TRIP in TNF-dependent and –independent processes. 
Despite efforts using a variety of approaches, we are not able to localize NOPO in 
the early embryo. Therefore, we cannot perform co-localization experiments between 
NOPO and Y-family polymerases. Using a transgenic line expressing HA-DNApol-eta, 
we show that HA-DNApol-eta is localized to the nucleus during S-phase of syncytial 
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embryogenesis. The localization of HA-DNApol-eta in the nopo mutant background was 
difficult to assess, however, as we found in preliminary experiments that these embryos 
arrested earlier than the control nopo-derived embryos. While follow-up experiments are 
needed, these data would be consistent with our model that NOPO plays a critical role in 
limiting the activity of DNApol-eta in the early embryo.  
Further experimentation is required to determine if NOPO directly ubiquitylates 
the Y polymerases during early embryogenesis. A key experiment in addressing this 
question would be to perform in vivo ubiquitylation assays in early embryos null for 
nopo. Based on our observation that ubiquitylation of HA-DNApol-eta in S2 cells is 
enhanced when NOPO is co-expressed, we predict that HA-DNApol-eta ubiquitylation 
will be reduced or undetectable in nopo-null embryos. Such a result would more 
definitively point to a role for the NOPO E3 ligase in regulating Y-family polymerases 
during early embryogenesis of Drosophila. We do not see a detectable decrease in the 
levels of Y polymerases in the presence of NOPO/TRIP. Given that K63-linked ubiquitin 
chains generally act as non-proteolytic signals (Spence et al., 1995; Aguilar and 
Wendland, 2003), we propose that NOPO/TRIP E3s mediate assembly of K63-linked 
polyubiquitin chains on the Y polymerases to preserve genomic integrity in mammalian 
cells and in early embryogenesis of Drosophila. 
We propose that Drosophila DNApol-eta has a unique role during early 
embryogenesis and that its activity and association with chromatin is regulated by NOPO. 
We favor a model in which NOPO ubiquitylates Y-family DNA polymerases during S-
phase of early Drosophila embryogenesis and that ubiquitylation of these polymerases by 
NOPO regulates their localization and interaction with chromatin. More specifically, we 
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predict that NOPO-dependent ubiquitylation of the Y-family polymerases results in their 
sequestration away from the chromatin so that canonical polymerases can bind to the 
chromatin and promote high-fidelity DNA synthesis. 
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CHAPTER V 
 
MATERIALS AND METHODS 
 
DROSOPHILA STOCKS 
 Flies were maintained at 25˚C using standard techniques. y w was used as wild 
type unless otherwise indicated. cn Z2-1447 bw/CyO was a gift from Charles Zuker; 
UASp-His7-Ub was a gift from Lynn Cooley; ben1 and mnk6006 stocks were from Mark 
Tanouye and Bill Theurkauf, respectively; and the EYG5845 stock was from GenExel 
(Seoul, Korea). Other fly stocks were from Bloomington or Szeged stock centers. 
 
QUANTIFICATION OF EGG HATCH RATES 
 Five newly eclosed females of the indicated genotype and five wild-type males 
were incubated in yeast-pasted vials for two days and transferred to egg-collection 
chambers at 25˚C. Eggs were collected daily over five days and scored for hatching ~40 
hours post-collection (>500 eggs per genotype). Hatch rate is the ratio of hatched to total 
eggs expressed as a percentage.  
 
GENETIC AND MOLECULAR MAPPING OF nopo   
 We screened a second chromosome deficiency collection for non-
complementation of female sterility of nopoZ1447. Females carrying nopoZ1447 in trans to 
any of several overlapping deficiencies (Df(2R)Pcl-11B, Df(2R)Pcl-XM82, Df(2R)Pcl-7B, 
or Df(2R)PC4) were sterile, placing nopo in the 55A1-C1 interval.  
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We further mapped nopoZ1447 by P-element-induced male recombination (Chen et 
al., 1998) relative to several insertions: lolalEP2169, Dgp-1BG00396, CG5721EY03388, fjKG03419, 
and EP(2)1081. Multiple independent recombinant chromosomes were recovered for 
each P-element tested. We narrowed nopo to five candidates in the 55B11-12 region 
(Dgp-1, CG10916, CG5726, CG5140, and CG5721) distal to Dgp-1BG00396 and proximal 
to CG5721EY03388 as annotated on FlyBase (Grumbling and Strelets, 2006). 
  For each candidate gene, coding regions were sequenced as described (Rickmyre 
et al, 2007). nopoZ1447 is a missense mutation in CG5140 causing a glutamic acid to lysine 
change at residue 11 of the predicted protein. Df(2R)Exel7153, which deletes 15 genes in 
this region, was subsequently found to uncover nopo. 
Putative nopo homologs were identified using HomoloGene (release 56), and 
NOPO's RING domain was identified using ScanProsite.  
 
GENERATION OF nopo-NULL ALLELE 
 A nopo-null allele was generated by imprecise excision of P-element EYG5845. 
The 771-bp deletion nopoExc142 lacks part of the 5'-UTR and exons encoding residues 1-
181.  
 
cDNA CLONES 
 cDNA encoding NOPO, BEN, UEV1A, DNApol-eta, DNApol-iota, dRev1, 
MAGO, and CG30291 (GH03577, LD24448, LD28904, SD05329, LD29090, GH11153, 
RE14116, and GH19637 respectively) were from the Drosophila Gene Collection. 
Human TRIP cDNA (ID 2821007) and MAGOH (ID 3861094) were from Open 
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Biosystems. Plasmids containing human POLH, POLI, POLK, and REV1 were a gift 
from Peter Guengerich. Plasmids containing human MDM2 and LZAP were gifts from 
Christine Eischen and Dell Yarbrough, respectively. 
 
TRANSGENESIS 
A 3.8 kb genomic fragment containing CG5140 and flanking regions (Fig. 2.2A) 
was PCR-amplified from BAC clone BACR15G20 (Drosophila Genomics Resource 
Center) and subcloned into pCaSpeR4. A transgenic line carrying pCaSpeR4-CG5140 
was generated by P-element-mediated transformation via embryo injection (Rubin and 
Spradling, 1982).  
For nopo cDNA and hTRIP cDNA rescue experiments pCaSpeR4-CG5140 was 
used as a template for PCR in order to excise the nopo gene between the 5’- and 3’-
UTRs. nopo or human TRIP cDNA was subsequently subcloned into the excised region 
(Fig. 3.1A). Transgenic lines carrying pCaSpeR4-nopogennopocDNA or pCaSpeR4-
nopogenhTRIPcDNA were generated.  
For DNApol-eta rescue and overexpression experiments, cDNA encoding 
DNApol-eta was PCR-amplified from clone SD05329 (Drosophila Genomics Resource 
Center) and subcloned into a HA-tagged version of UASp (Rørth, 1998). A transgenic 
line carrying pUASp-HA-DNApol-eta was generated. 
 
EMBRYO IMMUNOSTAINING AND MICROSCOPY 
 Methods for fixation, staining, and fluorescence microscopy of embryos (1.5-2.5 
hours unless otherwise indicated) and live-image analysis were previously described 
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(Rickmyre et al., 2007). P-values for live-image data were obtained using a two-tailed 
unpaired Student’s t-test. 
 
NOPO POLYCLONAL ANTIBODIES 
 A fusion consisting of an N-terminal MBP tag and C-terminal NOPO was used to 
generate anti-NOPO antibodies. DNA encoding C-terminal NOPO (residues 224 to 435) 
was PCR-amplified and subcloned into pMAL (New England Biolabs). MBP-C-NOPO 
was produced in bacteria, purified using amylose resin, and injected into guinea pigs 
(Covance).  
 
PROTEIN EXTRACTS AND IMMUNOBLOTS 
 In Chapter 2, protein extracts were made by homogenizing embryos (1-2 hours) 
or dissected tissues in urea sample buffer (Tang et al., 1998). Proteins were transferred to 
nitrocellulose for immunoblotting using standard techniques. Antibodies were used as 
follows: guinea pig anti-NOPO (1:1000), mouse anti-GAPDH (1:1000, Abcam), mouse 
anti-α-tubulin (DM1α, 1:5000, Sigma), mouse anti-Cyclin B (F2F4, 1:200, 
Developmental Studies Hybridoma Bank), and rabbit anti-pY15-Cdk1 (1:1000, Upstate).  
 
MAMMALIAN CELL TRANSFECTION, STAINING, AND MICROSCOPY 
 HeLa cells were maintained in Dulbecco’s modified Eagle Medium (DMEM) 
containing 10% fetal bovine serum. Plasmids encoding N-terminally tagged (eGFP or 
mCherry) versions of NOPO, TRIP, and BEN generated by subcloning into pCS2 were 
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transfected into cells using Lipofectamine 2000 (Invitrogen) according to manufacturer’s 
directions.   
 Cells were plated on fibronectin-coated coverslips 21 hours post-transfection and 
fixed three hours later. For direct fluorescence and centromere staining, cells were fixed 
20 minutes with 4% formaldehyde in CBS (10 mM MES pH 6.1, 138 mM KCl, 3 mM 
MgCl2, 2 mM EGTA, 0.32 M sucrose). For PCNA staining, cells were fixed 5 minutes in 
70% methanol/30% acetone. For Cyclin A staining, cells were fixed 20 minutes in 3% 
paraformaldehyde/20% sucrose in phosphate-buffered saline. Cells were permeabilized 
10 minutes with 0.5% Triton X-100 in Tris-buffered saline. Primary antibodies were used 
as follows: human autoimmune (CREST) serum (1:1000, ImmunoVision), Cyclin A (H-
432, 1:100, Santa Cruz Biotechnology), and PCNA (PC10, 1:200 Santa Cruz 
Biotechnology). To visualize actin, cells were stained one hour with fluorescently 
conjugated phalloidin (1:1000, Invitrogen). Fluorescently conjugated secondary 
antibodies were used at 1:5000. Slides were mounted in Vectashield with DAPI (Vector 
Labs). Images were acquired using a Nikon Eclipse 80i microscope equipped with a 
CoolSNAP ES camera (Photometrics) and Plan-Apo 60X objective. For experiments 
involving quantification, at least 400 cells per condition were scored.  
 
YEAST TWO-HYBRID ASSAYS 
 In Chapter 2, yeast two-hybrid assays were performed as described (James et al., 
1996). Plasmids expressing wild-type and mutant versions of NOPO, BEN, and UEV1A 
fused to Gal4 DNA binding domain (“bait” vector pGBD-C) or Gal4 activation domain 
(“prey” vector pGAD-C) were transformed into S. cerevisiae strain PJ69-4A. Cells 
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containing both bait and prey plasmids were selected by growth on synthetic complete 
(SC) plates lacking tryptophan and leucine and spotted onto SC plates lacking 
tryptophan, leucine, and histidine; growth on the latter (scored after two days at 30˚C) 
indicates physical interaction between fusion proteins tested.  
In Chapter 3, full-length or truncated versions of human TRIP or Drosophila 
NOPO were subcloned into pGBKT7 and subsequently transformed into yeast strain 
AH109 (Clontech). Full-length or truncated cDNAs of human POLH, POLI, POLK, and 
REV1 or Drosophila DNApol-eta, DNApol-iota, and dRev1 were subcloned into pGADT7 
to encode a hybrid protein containing the Gal4 activation domain. Truncation constructs 
were made by PCR cloning. Prey constructs were transformed into strain Y187 and 
mated with yeast strain AH109 expressing a bait plasmid. Diploid cells expressing both 
bait and prey constructs were selected by growth on selective media lacking Leu and Trp 
(double dropout, DDO). Dilutions were made from a colony grown on DDO media 
resuspended in sterile water and serial diluted 1:10, 1:100 and 1:1000. Interactions were 
tested by spotting diluted cells onto TDO medium and scoring growth after 3 days at 
30°C. Side by side plating on DDO was performed as a control. 
 
DROSOPHILA DNA DAMAGE RESPONSE ASSAYS 
 Sensitivity of nopo larvae to hydroxyurea or irradiation was tested as described 
(Rickmyre et al., 2007). 
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BEHAVIORAL ASSAYS AND TDT MORPHOLOGY 
To assess the visually mediated jump response, white-eyed control (w1118) and 
mutant flies (two days old) were dark adapted, transferred without anesthesia to a Petri 
dish covered in vellum, and exposed to a "lights off" stimulus using an LED light 
apparatus as described (Fayyazuddin et al., 2006). Ten males per genotype were each 
tested in ten trials separated by 30 seconds. Climbing ability of adult males was assessed 
as described (Silva et al., 2004) with three replicates per genotype. P-values were 
obtained using two-tailed unpaired Student’s t-tests. To visualize TDT muscle attachment 
sites, adult males (30 per genotype) were ventrally transilluminated with a dissecting 
microscope lamp as described (Edgecomb et al., 1993). 
 
INNATE IMMUNITY ASSAY 
Adult males (5-7 days old) were injected using a Drummond Nanoject with ~50 
nanoliters of an overnight culture of E. coli resuspended in phosphate-buffered saline. Six 
hours later, RNA was isolated by homogenizing flies in STAT-60 buffer according to 
manufacturer’s directions (Isotex Diagnostics). Following DNase treatment, cDNA was 
prepared by reverse transcription using Superscript II (Invitrogen). A diptericin-specific 
LUX primer (Invitrogen) was used to perform quantitative real-time PCR with the 7300 
Real-Time PCR System (Applied Biosystems). diptericin levels were normalized to Rp49 
levels as an endogenous control. Results from three independent experiments were 
averaged and further normalized against buffer-injected Canton S flies. P-values were 
obtained using a two-tailed unpaired Student’s t-test.  
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THE YEAST TWO-HYBRID SCREEN 
Human TRIP cDNA was amplified by PCR and subcloned into pGBKT7 to 
encode a hybrid protein containing the DNA-binding domain of Gal4 (Clontech). Yeast 
cells of the AH109 strain were transformed with pGBKT7-hTRIP and mated with yeast 
cells pretransformed with a HeLa cDNA library according to manufacturer’s directions 
(Clontech). Expression was determined by SDS-PAGE and immunoblotting, and X-α-
galactosidase activity was assessed as a measure of transactivation. Transformants were 
selected on minimal media lacking His, Leu, and Trp (triple dropout, TDO) selection 
medium. Positive prey plasmids were sequenced and retested on TDO selection medium 
to confirm the interactions. 
 
DROSOPHILA CELL CULTURE AND TRANSFECTIONS 
Drosophila S2 cells were maintained in Schneider’s media (Invitrogen) 
containing 10% fetal bovine serum. Plasmids generated by subcloning into tagged 
versions of pRmHa3 were transiently transfected into cells using the calcium phosphate 
method as previously described (March et al., 2010). ~24 hours after transfection, cells 
were washed and replated in fresh media, and expression was induced with 1 mM CuSO4. 
 
EXTRACT PREPARATION AND IMMUNOPRECIPITATION 
For mammalian cell studies, cell lysates and immunoprecipitation were performed 
as previously described (Kim et al., 1999). HeLa cells were transiently transfected with 2 
µg HA-POLH, HA-POLI, or FLAG-POLK and 1 µg MYC-hTRIP or empty vector. 24 
hours after transfection, cells were washed with PBS and then lysed in non-denaturing 
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lysis buffer (NDLB; 1% Triton X-100, 150 mM NaCl, 10 mM TrisHCl, pH 7.5, 1 mM 
EDTA, 1 mM EGTA, protease inhibitors). Lysates were centrifuged for 15 min at 13,000 
rpm and were frozen at -80°C. Cell lysates containing 700 µg of total protein were 
incubated with shaking for 2 hours at 4°C with 50 µl of Protein A/G agarose beads (Santa 
Cruz). The beads were washed 3X with NDLB and 2X with PBS. Bound proteins were 
analyzed by SDS-PAGE and immunoblotting. 
For Drosophila cell studies, cell lysates and immunoprecipitation were performed 
as above. S2 cells were transiently transfected with 3 µg pRmHa3-MYC-NOPO or empty 
vector and 5 µg pRmHa3-HA-DNApol-eta or pRMHa3-HA-DNApol-iota. 24 hours after 
induction with CuSO4, cells were washed with PBS and then lysed in NDLB. 
Immunoprecipitation, SDS-PAGE, and immunoblotting were performed as described 
above. 
For Drosophila embryo studies, embryos were dechorionated in 50% bleach and 
washed with distilled water. Embryos were lysed in NDLB by homogenization with a 
pestle. Lysates were centrifuged for 15 minutes at 13,000rpm and were frozen at -80 °C. 
For immunoprecipitation, embryo lysates containing 700 µg total protein were incubated 
with Protein A/G agarose beads (Santa Cruz) and anti-MYC antibodies (clone 9E10) and 
washed as described above. Bound proteins were analyzed by SDS-PAGE and 
immunoblotting. 
 
UBIQUITYLATION ASSAYS 
 For mammalian cell studies, we used the previously established His6-Ubiquitin 
method (Treier et al., 1994; Campanero and Flemington, 1997). ~1X106 HeLa cells were 
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transfected 16 hours after plating onto a 6 cm dish. Cells were transiently transfected with 
1 µg Myc-hTRIP or empty vector and 2 µg HA-POLH, HA-POLK, or FLAG-POLI in 
the absence or presence of 1 µg pMT107 (gift of Dirk Bohmann and William Tansey), 
which encodes His6-human ubiquitin. After 24 h of incubation with the DNA complexes, 
cells were harvested and histidine-tagged proteins purified on Nickel-nitrilotriacetic acid 
(Ni-NTA) agarose (Qiagen) exactly as previously described (Campanero and Flemington, 
1997). Bound proteins were detected by SDS-PAGE and immunoblotting as described 
above. 
 For Drosophila S2 cell studies, we modified the method described above using a 
plasmid we generated to express Histidine-tagged ubiquitin in S2 cells, pRmHa3-His6-
ubiquitin. 3X106 cells were transfected 16 hours after plating onto a 6 cm dish. Cells were 
transiently transfected with 3 µg pRmHa3-MYC-NOPO or empty vector and 5 µg 
pRmHa3-HA-DNApol-eta in the absence or presence of 2 µg pRmHa3-His6-ubiquitin. 24 
h after induction with CuSO4, cells were harvested and histidine-tagged proteins purified 
on Ni-NTA agarose (Qiagen) as described above. Bound proteins were detected by SDS-
PAGE and immunoblotting as described above. 
 For Drosophila embryo studies, we used transgenes expressing UASp-His7-
Ubiquitin (gift of Lynn Cooley) and UASp-HA-DNApol-eta. We expressed HA-
DNApol-eta, in the presence or absence of His7-ubiquitin, using the driver nanos-Gal4 in 
the female germ line of wild type or nopo mutant females. 0-3 hour embryos were 
collected, lysed under denaturing conditions as described above, and histidine-tagged 
proteins were purified on Ni-NTA agarose (Qiagen) as described above. Bound proteins 
were detected by SDS-PAGE and immunoblotting as described above. 
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UV TREATMENT OF CULTURED CELLS 
HeLa cells were washed with PBS and treated with UV at 80-100% confluency. 
UV treatment was at 20 J/m2. Recovery was in complete medium for 6 hours. 
 
RNA EXTRACTION AND ANALYSIS 
 RNA was extracted from 0-3 hour embryos using RNA STAT-60 (Tel-Test, Inc.) 
and reverse transcribed (RT) using the High Capacity cDNA RT Kit (Applied 
Biosystems). Reactions lacking RT were performed as a control. Polymerase chain 
reaction (PCR) was performed using RT reaction products as template. PCR products 
were resolved by agarose gel electrophoresis. 
 
GENERATION OF DNApol-eta NULL ALLELE 
A DNApol-eta-null allele was generated by imprecise excision of P-element 
EY07711. The 2.1 kb deletion DNApol-etaExc176 lacks part of the 5'-UTR and exons 
encoding residues 1-598. 
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CHAPTER VI 
 
CONCLUDING REMARKS 
 
SUMMARY 
In a screen for cell-cycle regulators, we identified a Drosophila maternal effect-
lethal mutant that we named “no poles” (nopo). Embryos from nopo females undergo 
mitotic arrest with barrel-shaped, acentrosomal spindles during the rapid S-M cycles of 
syncytial embryogenesis. We identified CG5140, which encodes a candidate RING 
domain-containing E3 ubiquitin ligase, as the nopo gene. A conserved residue in the 
RING domain is altered in our EMS-mutagenized allele of nopo, suggesting that E3 
ligase activity is critical for NOPO function. We showed that mutation of a DNA 
checkpoint kinase, Chk2, suppresses the spindle and developmental defects of nopo-
derived embryos, revealing that activation of a DNA checkpoint operational in early 
embryos contributes significantly to the nopo phenotype. Chk2-mediated mitotic arrest 
has been previously shown to occur in response to mitotic entry with DNA damage or 
incompletely replicated DNA. Syncytial embryos lacking NOPO exhibit a shorter 
interphase during cycle 11, suggesting that they may enter mitosis prior to completion of 
DNA replication. We showed that Bendless (BEN), an E2 ubiquitin conjugating enzyme, 
interacts with NOPO in a yeast two-hybrid assay; furthermore, ben-derived embryos 
arrest with a nopo-like phenotype during syncytial divisions. These data support our 
model that an E2-E3 ubiquitination complex consisting of BEN-UEV1A (E2 
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heterodimer) and NOPO (E3 ligase) is required for preservation of genomic integrity 
during early embryogenesis. 
NOPO is the Drosophila homolog of mammalian TRAF-interacting protein 
(TRIP). NOPO and TRIP contain highly similar RING domains that closely resemble that 
of known E3 ubiquitin ligases. We sought to elucidate the mechanism by which 
NOPO/TRIP promotes genomic stability by performing a yeast two-hybrid screen to 
identify NOPO/TRIP interactors and/or substrates. We identified several interesting 
proteins that are involved in immune signaling, apoptosis and the cell cycle. One protein 
is a member of a family of non-canonical DNA polymerases that facilitate the replicative 
bypass of damaged DNA (translesion synthesis, TLS). In mammals, there are four Y-
family DNA polymerases: POLH, POLI, POLK and REV1. Mutation of one of the 
human Y-family polymerases, POLH, results in a variant form of Xeroderma 
Pigmentosum, a disease characterized by UV sensitivity and skin cancer. We showed that 
TRIP interacts with all of these TLS polymerases via yeast two-hybrid assays and co-
immunoprecipitation from cultured mammalian cells.  
The Y-family polymerases conserved in Drosophila are DNApol-eta, DNApol-
iota and Rev1. We showed that Drosophila NOPO interacts with these Y polymerases via 
yeast two-hybrid assays as well as co-immunoprecipitation from cultured Drosophila S2 
cells and early embryos. We also showed that TRIP and NOPO E3 ligases enhance the 
ubiquitylation of the Y-family polymerases in cultured mammalian and Drosophila cells, 
respectively. Furthermore, co-expression of TRIP and POLH in cultured mammalian 
cells alters POLH’s localization by recruiting it to the nucleolus with TRIP.  
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In C. elegans, POLH-1, the DNApol-eta homolog, has been proposed to prevent 
stalling of replication forks during the early embryonic cell cycles by quickly responding 
to and bypassing lesions, thereby keeping these rapid cell cycles on schedule. We 
generated a null DNApol-eta mutant line and found that these mutant females have 
reduced fertility and produce embryos with nopo-like spindle defects. Together, these 
data suggest that DNApol-eta has a unique role during early Drosophila embryogenesis 
to promote cell-cycle progression and that NOPO regulates its activity. We hypothesize 
that NOPO ubiquitylates Y-family DNA polymerases during S-phase of early Drosophila 
embryogenesis so as to control their localization and interaction with chromatin at sites of 
DNA damage.  
 
DISCUSSION AND FUTURE DIRECTIONS 
TRIP is a RING-dependent E3 ubiquitin ligase, but ubiquitylation substrates of 
TRIP have not yet been reported (Besse et al., 2007). TRIP is also implicated in 
apoptosis; a recent study showed that the tumor suppressor Syk phosphorylates TRIP and 
that overexpression of TRIP sensitizes cells to TNF-induced apoptosis (Zhou and 
Geahlen, 2009). TRIP plays a TNF-independent role in cell proliferation: when TRIP is 
knocked down in keratinocytes, cells exhibit an NF-κB-independent G1/S phase cell-
cycle arrest (Almeida et al., 2011).  
In future experiments, it would be interesting to use cultured keratinocytes to 
study the role of endogenous TRIP in mammalian cells. Because we have not been able 
to detect TRIP expression in the cultured mammalian cells that we had readily available 
in the lab (data not shown), we cannot knock down TRIP expression by RNAi in our cell 
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lines to study its loss of function phenotype. Performing TRIP RNAi experiments in a 
cell line expressing endogenous TRIP would be extremely useful to study the 
ubiquitylation and regulation of the Y-family DNA polymerases. These experiments 
could address the specificity of TRIP’s ubiquitylation of the Y-family polymerases and 
may help to identify other potential substrates of TRIP in vivo. 
Direct confirmation for ubiquitylation of the Y-family DNA polymerases by 
NOPO/TRIP would require in vitro approaches. This would involve adding in vitro-
translated, radiolabeled substrate proteins to purified E1, the E2 (BEN-UEV1A or 
UBC13-UEV1A), NOPO or TRIP, Ub, and ATP. Following incubation, the readout for 
ubiquitylation of the Y polymerase substrates would be to see an upward mobility 
shift/laddering of the radiolabeled proteins, consistent with ubiquitylation. This approach 
could also establish whether BEN-UEV1A (or UBC13-UEV1A) is the E2 heterodimer 
involved in the ubiquitylation of the Y polymerases by NOPO/TRIP. 
Once in vitro assays are established, there are many other important biochemical 
questions that could be addressed. First, we could attempt to identify the lysine residue(s) 
that is/are ubiquitylated on the Y polymerases by NOPO/TRIP. We could also determine 
the type of polyubiquitin linkage on these polymerases. This can be done using 
established ubiquitin mutants (i.e. K0, K11R, K48R, K63R) and observing the 
ubiquitylation pattern of the substrate in the presence of NOPO/TRIP compared to wild-
type ubiquitin. These experiments are technically difficult to perform in cultured cells, 
likely due to high levels of endogenously expressed ubiquitin, which may compete with 
the transfected mutant forms for incorporation into substrates. Such restrictions in 
cultured cells make the suggested in vitro approaches invaluable.  
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We predict that NOPO/TRIP E3s mediate assembly of K63-linked ubiquitin 
chains on their substrates to preserve genomic integrity. While K48-linked ubiquitin 
chains have established roles in targeting proteins for proteasome-mediated degradation, 
K63-linked ubiquitin chains are not thought to act as proteolytic signals (Pickart and 
Fushman, 2004). In the presence of NOPO/TRIP, we do not see a detectable decrease in 
the levels of Y polymerases. Furthermore, in budding yeast and mammalian cells, the E2 
heterodimers Ubc13-Mms2 and Ubc13-Uev1A mediate K63 ubiquitin chain assembly on 
target proteins. Additional investigation into the type of polyubiquitin linkage will be 
critical in elucidating the mechanism by which NOPO/TRIP E3s regulate cell-cycle 
progression. 
Another way to establish that NOPO/TRIP is responsible for ubiquitylation of the 
Y-family polymerases is to specifically perturb the E3 ligase activity of TRIP by making 
mutations in the E3. The RING domain of E3 ubiquitin ligases is likely involved in 
mediating protein-protein interactions, most commonly to its partner E2(s). Therefore, by 
mutating the RING domain, the E3 will no longer be able to bind the E2(s), and ubiquitin 
cannot be transferred to the substrate protein. We have generated several constructs to 
address this issue: (1) a D12K mutation in TRIP alters the evolutionarily conserved 
residue that is mutated in our nopoZ1447 mutants (E11K), (2) a C7A mutation in the first 
cysteine of TRIP’s RING domain, previously reported to disrupt mouse TRIP’s E3 ligase 
function in vitro, (3) a I9A mutation that is predicted to disrupt the conformation of the 
RING domain, and (4) a delta RING mutant in which the entire RING domain is deleted. 
The individual point mutations (1-3), however, did not change TRIP’s E3 ligase activity 
in our cultured cell assays, while the delta RING mutant TRIP (4) was unstable when 
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overexpressed in human cells (data not shown). In order to completely disrupt TRIP’s E3 
activity, we predict that we must mutate all of the cysteine and histidine residues within 
TRIP’s RING domain. Once these mutations are made, TRIP’s E3 ligase function can be 
further tested. Such experiments would also be interesting to perform for NOPO in 
cultured Drosophila S2 cells. We have shown that the E11K mutation of NOPO disrupts 
its interaction with BEN via yeast two-hybrid assays, so we would predict that this 
mutation would also disrupt its E3 ligase activity when overexpressed in S2 cells (Merkle 
et al., 2009). The results of these experiments would be very informative to further 
understand NOPO/TRIP’s E3 ligase activity. 
There is evidence that mammalian TRIP is important during development. Mouse 
TRIP is needed for early embryonic development: homozygous mutant mouse embryos 
die shortly after implantation due to proliferation defects and excessive cell death (Park et 
al., 2007). This early embryonic arrest occurs prior to when TNF signaling is first 
required during embryogenesis, suggesting that TRIP has roles outside of its proposed 
TNF-signaling functions (Gerhart, 1999). Another developmental role suggested for 
TRIP involves TNF/NF-κB-dependent sexual dimorphism in developing neurons 
(Krishnan et al., 2009). This study showed an upregulation of TRIP in the developing 
male anteroventral periventricular (AVPV) nucleus, a region that is larger in females and 
critical for regulating the release of female-specific luteinizing hormone (LH). The size 
difference in male versus female AVPV nuclei results from apoptosis in developing male 
neurons. Although some of the roles for TRIP may occur through TNF signaling, others 
clearly are not. Further investigation is likely to reveal new roles for TRIP in TNF-
dependent and –independent developmental processes.  
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We have begun preliminary studies to look at the role of TRIP during vertebrate 
development using early Xenopus embryos. Antisense morpholino-mediated depletion of 
TRIP in Xenopus embryos results in an embryonic developmental arrest (our unpublished 
data), confirming that TRIP is needed during early embryonic development in 
vertebrates. Future efforts will focus on the use of developmental markers to further 
elucidate TRIP’s role in Xenopus embryogenesis. 
As discussed earlier, it will be important to study the loss of function phenotype 
of TRIP in order to better understand its roles.  Other than RNAi, another way to address 
this would be to obtain the TRIP mutant mice generated by Park et al. (2007) and attempt 
to isolate MEFs (mouse embryonic fibroblasts) from the homozygous mutant embryos. 
These TRIP-null MEFs would be an ideal system to look at the regulation and 
localization of the Y polymerases in the absence of TRIP compared to wild-type mouse 
MEFs. A major caveat of this approach, however, is that MEFs are difficult to transiently 
transfect, and endogenous Y polymerases have been difficult to detect by 
immunostaining. If TRIP-null MEFs could be isolated and cultured, it would be very 
interesting to investigate TRIP’s regulation and ubiquitylation of the Y polymerases in 
mammalian embryonic cells. We could then determine if TRIP’s role in mammalian 
embryogenesis is analogous to that of NOPO’s role during Drosophila embryogenesis. 
Future efforts should also focus on dissecting the interactions of TRIP with the 
candidate hits identified in our yeast two-hybrid screen. One group of interactors is 
associated with apoptosis and NF-κB signaling. There is also evidence that TRIP has 
roles outside of TNF-signaling. We identified MDM2 and LZAP in our yeast two-hybrid 
screen for TRIP interactors, and we confirmed these interactions by demonstrating their 
 124 
coimmunoprecipitation from cultured mammalian cells. The developmental requirement 
for mammalian TRIP and Drosophila NOPO may be linked to MDM2 and/or LZAP 
because MDM2 and LZAP mutant mice also die in early embryonic development. It will 
be interesting to see if any of the proposed roles for TRIP in apoptosis and cell 
proliferation involve its interaction with LZAP and/or MDM2.  
It will also be important to determine if TRIP’s interactions with LZAP and 
MDM2 are that of an E3 ligase and its substrates. Since all of these proteins have been 
implicated in cell-cycle progression, genome maintenance and development, uncovering 
the mechanisms by which these proteins regulate these processes will be extremely 
informative. Although there is no obvious MDM2 homolog in Drosophila, by sequence 
similarity alone, p53 levels are regulated in flies, suggesting that an MDM2 may be 
functionally conserved in Drosophila (Sekelsky et al., 2000; Jin et al., 2000; Brodsky et 
al., 2004). We are particularly interested in future efforts to identify a Drosophila MDM2 
homolog and to study the potential roles of NOPO in regulating MDM2 and LZAP 
during early Drosophila embryogenesis. 
Although the function of TRIP at the nucleolus has yet to be identified, this 
nuclear compartment has been shown to be a site at which proteins are sequestered and 
held inactive (Boisvert et al., 2007). The nucleolus is the site of ribosome biosynthesis 
and plays roles in other cellular processes. In the presence of DNA damage, MDM2 is 
sequestered to the nucleolus, so it cannot ubiquitylate and degrade the tumor suppressor 
p53 (Bond et al., 2005). Based on TRIP’s localization and interaction with MDM2, we 
favor a model in which TRIP ubiquitylates and sequesters its substrates to the nucleolus 
under certain cellular or environmental conditions. 
 125 
We have yet to fully elucidate the role of NOPO in regulating cell-cycle 
progression and genome maintenance during early Drosophila embryogenesis. We 
predict that NOPO’s function is conserved based on rescue of the sterility of nopo mutant 
females with a transgene expressing human TRIP. We predict that NOPO’s ubiquitylation 
of its substrates results in K63-liked polyubiquitylation and a subsequent change in its 
substrate’s subcellular localization. We base our model on results obtained from C. 
elegans in which DNApol-eta also has a unique role during early embryogenesis to 
control cell-cycle timing. We predict that Drosophila DNApol-eta also has a unique role 
in early embryogenesis and that its activity and association with chromatin is regulated 
by NOPO. We hypothesize that NOPO ubiquitylates Y-family DNA polymerases during 
S-phase of early Drosophila embryogenesis and that ubiquitylation of these polymerases 
by NOPO regulates their localization and interaction with chromatin. More specifically, 
we predict that NOPO-dependent ubiquitylation of the Y-family polymerases results in 
their sequestration away from the chromatin so that canonical polymerases can bind to 
the chromatin and promote DNA synthesis. 
 
SIGNIFICANCE 
Cell division is essential for the development of all tissues and organs within 
multicellular organisms. It is a fundamental facet of life, and the erroneous segregation of 
genetic information may result in developmental disorders or disease states, such as 
cancer. If the regulation of cell-cycle components is perturbed during critical 
developmental stages, sterility or developmental disorders may result. Cancer can result 
from the mutation or dysfunction of key cell-cycle regulators. Spontaneous mutations 
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arise with each cell division, and if those mutations are not corrected or if the mutated 
cells are not prevented from dividing, this may result in unregulated growth. A more 
complete understanding of the cell-cycle machinery and how developmental defects and 
cancers progress will lead to more effective therapeutics in order to fight these diseases. 
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